Other congenital malformations

Q17_OTHER_CONGEN_MALFO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q80-Q89 Cause of death: ICD-10 — Q80-Q89 2 out of 7 registries used, show all original rules.	3654
4. Check minimum number of events None	3654
5. Include endpoints Q17_CONGEN_ICHTHYOSIS Q17_EPIDERMOL_BULLOSA Q17_OTHER_CONGEN_MALFO_SKIN Q17_CONGEN_MALFO_BREAST Q17_OTHER_CONGEN_MALFO_INTEG Q17_PHAKOMATOSES_NOT_ELSEW_CLASSIFIED Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED Q17_OTHER_SPECIFE_CONGEN_MALFO_SYNDR_AFFECTING_MULTIPLE_SYSTEMS Q17_OTHER_CONGEN_MALFO_NOT_ELSEW_CLASSIFIED	3654
6. Filter based on genotype QC (FinnGen only)	3654

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Q
Name in latin: Aliae malformationes congenitae

NAME	Q17_OTHER_CONGEN_MALFO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	Q17_CONGEN_ICHTHYOSIS\|Q17_EPIDERMOL_BULLOSA\|Q17_OTHER_CONGEN_MALFO_SKIN\|Q17_CONGEN_MALFO_BREAST\|Q17_OTHER_CONGEN_MALFO_INTEG\|Q17_PHAKOMATOSES_NOT_ELSEW_CLASSIFIED\|Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED\|Q17_OTHER_SPECIFE_CONGEN_MALFO_SYNDR_AFFECTING_MULTIPLE_SYSTEMS\|Q17_OTHER_CONGEN_MALFO_NOT_ELSEW_CLASSIFIED
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q8
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q8
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other congenital malformations based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	36015	21253	14666
Only index persons	29245	17832	11413
Unadjusted period prevalence (%)
Whole population	0.53	0.61	0.41
Only index persons	0.57	0.66	0.44
Median age at first event (years)
Whole population	17.09	21.53	10.53
Only index persons	22.14	26.49	15.34

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3654	2496	1158
Unadjusted period prevalence (%)	0.74	0.85	0.51
Median age at first event (years)	36.07	34.84	38.72

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3289: Matched controls
32856

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q82.58

ICD-10 Finland

Congenital non-neoplastic naevus

107.8

323.0

571

Q83.8

ICD-10 Finland

Other congenital malformations of breast

3084.0

307.9

293

Q82.50

ICD-10 Finland

Naevus flammeus

1256.4

242.6

234

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

+∞

226.6

215

Q83.1

ICD-10 Finland

Accessory breast

2158.4

222.2

213

Z31.5

ICD-10 Finland

Genetic counselling

6.6

201.9

567

1001

Q87.4

ICD-10 Finland

Marfan syndrome

2010.3

187.1

180

Q82.2

ICD-10 Finland

Mastocytosis

1996.4

186.1

179

Q85.09

ICD-10 Finland

Unspecified neurofibromatosis

1516.2

148.0

143

ZXC12

NOMESCO Finland

Pulse colorlaser

103.2

135.2

148

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

60.3

127.6

150

Q82.51

ICD-10 Finland

Naevus portwine

123.8

121.9

131

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.5

117.4

456

1130

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

+∞

117.3

112

HAD10

NOMESCO Finland

Augmentation of breast using prosthesis

42.8

99.3

124

Q82.88

ICD-10 Finland

Other specified congenital malformations of skin

912.1

91.2

ZXE10

NOMESCO Finland

More than one and less than three hours

2.2

90.1

1270

7257

ZXD10

NOMESCO Finland

Scheduled procedure

2.1

86.9

1361

8120

Q85.0

ICD-10 Finland

Neurofibromatosis (nonmalignant)

+∞

86.8

Q89.23

ICD-10 Finland

Cyst of the ductus thyreoglossus

859.4

86.0

ZQX00

NOMESCO Finland

0-4% of the skin

139.9

77.3

HAC30

NOMESCO Finland

Excision of supernumerary mammary gland or mamilla

266.5

76.7

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

74.7

1016

5602

Q85.1

ICD-10 Finland

Tuberous sclerosis

+∞

73.2

Q82.80

ICD-10 Finland

Benign familial pemphigus [Hailey-Hailey]

+∞

71.1

Q89.7

ICD-10 Finland

Multiple congenital malformations, not elsewhere classified

+∞

66.9

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.7

65.6

311

903

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.7

64.2

301

866

Q85.01

ICD-10 Finland

Neurofibromatosis, type 2

+∞

63.7

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

62.8

819

4370

Q83.9

ICD-10 Finland

Congenital malformation of breast, unspecified

+∞

62.7

Z2221

NOMESCO Finland

Medical doctor

2.0

62.7

1025

6016

Q82.5

ICD-10 Finland

Congenital non-neoplastic naevus

21.2

57.1

ZXE00

NOMESCO Finland

One hour or less

1.8

56.2

1366

9171

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.3

54.2

602

2962

Q82.0

ICD-10 Finland

Hereditary lymphoedema

+∞

53.2

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

8.6

52.1

116

139

D18.0

ICD-10 Finland

Haemangioma, any site

6.0

50.9

145

249

ZXA10

NOMESCO Finland

Bilateral

2.2

50.2

617

3167

Q82.82

ICD-10 Finland

Inherited keratosis palmaris et plantaris

+∞

50.1

HAD40

NOMESCO Finland

Mastopexy

22.9

49.7

2377A

ICD-9 Finland

Neoplasm of uncertain behaviour of endocrine glands and nervous system, Neurofibromatosis

248.3

48.1

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

45.3

456

2122

Q87.09

ICD-10 Finland

Other congenital malformations that mainly affect the appearance of the face

453.3

45.3

R4110

NOMESCO Finland

Physiotherapy

1.9

45.1

839

5044

Q87.80

ICD-10 Finland

Alport syndrome

+∞

44.9

Z3226

NOMESCO Finland

Physiotherapist

2.0

44.7

654

3593

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

44.1

1135

7589

ZXA00

NOMESCO Finland

Right side

1.9

43.9

729

4200

QBA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of trunk

81.2

42.9

Z3231

NOMESCO Finland

Registered nurse

1.8

42.7

927

5856

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.3

41.9

448

2143

Q82.81

ICD-10 Finland

Keratosis follicularis [Darier-White]

+∞

41.7

ENB50

NOMESCO Finland

Excision of cyst or fistula of thyroglossic duct

37.7

41.0

ZZF00

NOMESCO Finland

Graft of adipose tissue

10.9

40.2

Q80.0

ICD-10 Finland

Ichthyosis vulgaris

+∞

39.6

Q82.9

ICD-10 Finland

Congenital malformation of skin, unspecified

+∞

38.6

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

6.0

38.0

108

185

Q87.14

ICD-10 Finland

Noonan's syndrome

+∞

37.5

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

37.3

317

1348

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

36.5

481

2512

Q80.9

ICD-10 Finland

Congenital ichthyosis, unspecified

+∞

36.5

Q83.3

ICD-10 Finland

Accessory nipple

+∞

36.5

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

4.6

36.4

130

290

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

35.5

481

2537

ZXA05

NOMESCO Finland

Left side

1.9

35.3

658

3910

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

35.0

275

1117

D47.0

ICD-10 Finland

Histiocytic and mast cell tumours of uncertain and unknown behaviour

124.6

34.7

F83

ICD-10 Finland

Mixed specific developmental disorders

5.5

34.7

106

199

HAD99

NOMESCO Finland

Other plastic operation on breast

12.3

34.6

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

33.6

591

3439

Z01.1

ICD-10 Finland

Examination of ears and hearing

2.1

33.4

440

2292

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

9.5

32.7

WX402

NOMESCO Finland

General anaesthesia

1.8

32.4

593

3491

Q82.8

ICD-10 Finland

Other specified congenital malformations of skin

+∞

32.3

XA800

NOMESCO Finland

Neuropsychological investigation

3.0

32.3

201

708

74340

ICD-8 Finland

Other congenital anomalies of nervous system, Neurofibromatosis

319.7

31.9

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

7.9

31.6

Q87.21

ICD-10 Finland

Klippel-Trénaunay-Weber syndrome

+∞

31.3

Q86.0

ICD-10 Finland

Fetal alcohol syndrome (dysmorphic)

+∞

31.3

Q89.9

ICD-10 Finland

Congenital malformation, unspecified

+∞

31.3

Q85.9

ICD-10 Finland

Phakomatosis, unspecified

+∞

31.3

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.5

30.7

266

1136

WX002

NOMESCO Finland

Sedation and analgesia

1.9

30.5

535

3095

9741/3-C42.1

ICD-O-3

Malignant mastocytosis of bone marrow

+∞

30.2

ZXC10

NOMESCO Finland

Use of laser

4.9

30.2

101

211

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

25.0

30.1

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

29.8

293

1336

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.9

29.7

187

664

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

5.6

28.9

157

R62.0

ICD-10 Finland

Delayed milestone

4.5

28.7

105

241

Z2446

NOMESCO Finland

Social worker

2.2

28.4

310

1484

ZXD20

NOMESCO Finland

Day surgery

2.0

28.2

409

2204

J01DB01

ATC

cefalexin; oral

1.6

28.0

2537

22318

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

27.5

502

2939

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

27.2

318

1569

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

8.7

27.2

E0000UV

ATC

1.5

26.7

1269

9617

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

7.9

26.6

D02AE01

ATC

carbamide; topical

2.4

26.6

246

1088

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

26.6

379

2029

QCA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of upper limb

94.0

25.7

F82

ICD-10 Finland

Specific developmental disorder of motor function

5.7

25.6

131

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.5

25.4

204

838

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

25.2

621

3978

H01AC01

ATC

somatropin; parenteral

5.9

25.2

122

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.4

25.2

231

1017

S18

ICPC

Laceration/cut

1.5

25.1

1084

8015

Q80.8

ICD-10 Finland

Other congenital ichthyosis

+∞

25.0

Q87.06

ICD-10 Finland

Velocardiofacial syndrome

+∞

25.0

Q87.19

ICD-10 Finland

Congenital malformation syndromes predominantly associated with short stature

+∞

25.0

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

4.0

24.8

102

262

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

24.2

285

1408

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

7.8

24.2

D05BB02

ATC

acitretin; oral

4.6

24.1

189

Q89.34

ICD-10 Finland

Cartagena syndrome (immotile cilia)

+∞

24.0

Q85.82

ICD-10 Finland

of Hipple-Lindau syndrome

+∞

24.0

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

9.9

24.0

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

31.2

23.7

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

23.6

719

4873

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.4

23.6

201

852

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

23.2

276

1369

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.6

22.9

171

674

R4120

NOMESCO Finland

Occupational therapy

2.3

22.8

214

953

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

22.3

439

2620

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.3

22.2

214

965

QDA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of lower limb

19.6

22.1

ZXD05

NOMESCO Finland

Urgent procedure

1.5

22.1

914

6649

HAD00

NOMESCO Finland

Augmentation mammoplasty

35.2

22.0

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.0

22.0

133

461

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

5.2

21.9

136

Q82.4

ICD-10 Finland

Ectodermal dysplasia (anhidrotic)

+∞

21.9

Q89.30

ICD-10 Finland

Situs inversus with dextrocardia

+∞

21.9

N03AF02

ATC

oxcarbazepine; oral

3.0

21.8

132

458

H52.2

ICD-10 Finland

Astigmatism

3.7

21.7

269

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

3.4

21.7

109

332

N02BE01

ATC

paracetamol; systemic, rectal

1.5

21.5

2454

21823

RL140

NOMESCO Finland

9.9

21.5

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.4

21.5

191

828

Q89.88

ICD-10 Finland

Other specified congenital malformations

+∞

20.8

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

12.4

20.8

P85

ICPC

Mental retardation

9.2

20.3

XQ848

NOMESCO Finland

Dermatological photography

3.9

20.2

214

101

Kela drug reimbursment

Anterior pituitary hypofunction

5.3

20.2

119

PD5BD

NOMESCO Finland

Extensive CT of aorta

5.5

20.2

111

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

15.1

20.2

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

3.1

20.1

112

368

Z2445

NOMESCO Finland

Psychologist

2.2

20.1

217

1033

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.1

20.0

112

369

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.5

19.9

273

XF404

NOMESCO Finland

Ambulatory ECG

2.1

19.8

232

1143

C96.2

ICD-10 Finland

Malignant mast cell tumour

+∞

19.8

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

19.4

193

884

E000001

ATC

1.6

19.3

654

4520

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.8

19.3

123

442

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

19.2

503

3256

I71.09

ICD-10 Finland

Aortic dissection [regardless of location]

18.3

19.1

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.5

19.0

154

636

XW000

NOMESCO Finland

Bone marrow biopsy

2.9

18.9

115

402

7598B

ICD-9 Finland

Other and unspecified congenital anomalies, Other specified anomalies[SYNDROMA MARFAN]

+∞

18.8

Q87.16

ICD-10 Finland

Mulibrey nanism

+∞

18.8

Q80.1

ICD-10 Finland

X-linked ichthyosis

+∞

18.8

Q87.8

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

+∞

18.8

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

2.3

18.6

182

826

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

18.5

518

3410

WX110

NOMESCO Finland

Local anesthesy

1.4

18.2

2194

19319

HAE99

NOMESCO Finland

Other reconstruction of breast

6.6

18.1

C03CA01

ATC

furosemide; systemic

1.6

18.0

462

2970

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

17.9

162

710

H52.1

ICD-10 Finland

Myopia

2.4

17.8

149

626

2280A

ICD-9 Finland

Haemangioma and lymphangioma, any site, Haemangioma, any site

26.8

17.8

Q87.30

ICD-10 Finland

Syndrome Beckwith-Wiedemann

+∞

17.7

Q80.2

ICD-10 Finland

Lamellar ichthyosis

+∞

17.7

Q81.0

ICD-10 Finland

Epidermolysis bullosa simplex

+∞

17.7

TQW99

NOMESCO Finland

Other minor procedure on skin

2.6

17.3

127

498

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.7

17.1

367

2241

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.9

17.1

281

1576

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

17.0

213

1077

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

11.6

17.0

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

16.9

687

4929

FM2CE

NOMESCO Finland

3.2

16.9

277

QBJ00

NOMESCO Finland

Liposuction in trunk

8.6

16.9

J01DA01

ATC

[U] cefalexin; systemic

1.4

16.9

1728

14695

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

16.8

276

1547

Q82.1

ICD-10 Finland

Xeroderma pigmentosum

+∞

16.7

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

16.5

253

1386

I34.1

ICD-10 Finland

Mitral (valve) prolapse

3.7

16.4

203

N02AX02

ATC

tramadol; systemic, rectal

1.4

16.2

973

7536

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

16.2

1075

8478

I71.00

ICD-10 Finland

Dissecting aneurysm of aorta (ruptured) [any part]

15.4

16.1

ZXC07

NOMESCO Finland

Carbon dioxide laser

21.0

15.9

R1260

NOMESCO Finland

Evaluation of communicative skills

4.0

15.8

160

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

6.8

15.7

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

15.7

352

2178

WX892

NOMESCO Finland

Monitored bed care

2.0

15.7

201

1030

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

15.6

252

1404

75988

ICD-8 Finland

Congenital syndromes affecting multiple systems, Aliae definitae

+∞

15.6

R4130

NOMESCO Finland

Speech therapy

3.1

15.5

289

N64.2

ICD-10 Finland

Atrophy of breast

22.1

15.5

H27.1

ICD-10 Finland

Dislocation of lens

13.8

15.5

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.4

15.4

220

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

3.7

15.4

179

AA1AD

NOMESCO Finland

CT of head and brain

1.6

15.3

472

3172

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.6

15.2

196

Q27.3

ICD-10 Finland

Peripheral arteriovenous malformation

16.1

15.2

D02AX

ATC

Other emollients and protectives

2.2

15.1

159

750

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

15.1

184

924

I71.01

ICD-10 Finland

Aneurysm of the descending aorta

20.1

15.1

Q21.08

ICD-10 Finland

Other specifed ventricular septal defect

4.9

15.1

102

Q21.10

ICD-10 Finland

Persistent ostium secundum

4.2

15.0

134

J01MA02

ATC

ciprofloxacin; systemic

1.4

14.9

875

6729

DFF00

NOMESCO Finland

Pure tone audiometry

2.0

14.9

203

1065

183

Kela drug reimbursment

Lamotrigin and topiramate

4.0

14.7

151

Q22.1

ICD-10 Finland

Congenital pulmonary valve stenosis

10.4

14.7

UJF32

NOMESCO Finland

Coloscopy

1.5

14.7

546

3830

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.6

14.7

110

437

ZXC50

NOMESCO Finland

Cryotherapy

3.7

14.6

172

Q89.22

ICD-10 Finland

Permanent ductus thyreoglossus

+∞

14.6

Q82.3

ICD-10 Finland

Incontinentia pigmenti

+∞

14.6

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

14.5

909

7063

Q53.2

ICD-10 Finland

Undescended testicle, bilateral

14.2

14.5

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

5.7

14.5

J01FF01

ATC

clindamycin; systemic

1.4

14.4

686

5064

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.3

14.4

139

631

Q35.1

ICD-10 Finland

Cleft hard palate

12.6

14.3

P01AB01

ATC

metronidazole; oral, rectal

1.4

14.3

1044

8326

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

5.7

14.2

UDC00

NOMESCO Finland

Ear microscopy

1.9

14.1

207

1112

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.5

14.1

110

447

N05BA01

ATC

diazepam; systemic, rectal

1.7

14.0

320

1989

R50.9

ICD-10 Finland

Fever, unspecified

1.6

14.0

423

2826

N03AX12

ATC

gabapentin; oral

1.6

13.8

363

2343

UGC02

NOMESCO Finland

Rigid bronchoscopy

7.1

13.8

RS220

NOMESCO Finland

3.5

13.7

187

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

6.9

13.6

XQ845

NOMESCO Finland

Dermatoscopy

5.2

13.6

Q87.26

ICD-10 Finland

VATER association

+∞

13.5

Q87.0

ICD-10 Finland

Congenital malformation syndromes predominantly affecting facial appearance

+∞

13.5

Q85.80

ICD-10 Finland

Peutz-Jegher syndrome

+∞

13.5

Q82.83

ICD-10 Finland

Congenital dyskeratosis

+∞

13.5

127

Kela drug reimbursment

Transplant complication

3.3

13.5

200

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.1

13.3

235

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

13.3

263

1565

RT160

NOMESCO Finland

6.6

13.2

M41.4

ICD-10 Finland

Neuromuscular scoliosis

13.8

13.2

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

7.3

13.2

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

4.0

13.2

132

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

13.2

472

3277

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

13.1

389

2584

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

13.1

144

691

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.1

13.1

151

742

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

12.2

13.1

KFH00

NOMESCO Finland

Operation for undescended or ectopic testis

7.1

13.0

QAA99

NOMESCO Finland

Other local destruction of skin of head or neck

11.0

13.0

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

13.0

970

7740

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.3

13.0

201

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

2.9

12.9

284

N03AX14

ATC

levetiracetam; systemic

2.7

12.9

345

D33.30

ICD-10 Finland

Acoustic neuroma

7.4

12.9

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

12.8

868

6811

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.8

12.8

294

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

12.7

362

2385

N03AX16

ATC

pregabalin; oral

1.5

12.7

526

3767

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

4.6

12.6

A12AA04

ATC

calcium carbonate; oral

3.6

12.6

153

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

12.6

156

790

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.9

12.5

183

986

TJD20

NOMESCO Finland

Change of gastrostomy tube

5.9

12.5

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.8

12.5

209

1180

75720

ICD-8 Finland

Congenital anomalies of skin, hair and nails, Iethyosis congenita

+∞

12.5

Q81.9

ICD-10 Finland

Epidermolysis bullosa, unspecified

+∞

12.5

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.8

12.5

139

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

3.3

12.5

191

Q27.4

ICD-10 Finland

Congenital phlebectasia

13.2

12.4

C07AB07

ATC

bisoprolol; oral

1.4

12.4

865

6811

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.2

12.4

127

594

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

12.3

1234

10272

A02BA02

ATC

ranitidine; systemic

1.5

12.3

400

2716

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

12.3

209

1189

22700

ICD-8 Finland

Haemangioma and lymphangioma, Haemangioma

14.3

12.2

Q53.1

ICD-10 Finland

Undescended testicle, unilateral

6.2

12.2

M79.6

ICD-10 Finland

Pain in limb

1.4

12.2

899

7140

181

Kela drug reimbursment

Retigabine and vigabatrin

10.5

12.2

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

12.2

168

885

SPAT1153

SPAT

Removal of sutures

1.4

12.2

706

5384

RS222

NOMESCO Finland

3.6

12.2

147

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.6

12.2

331

2154

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.6

12.1

287

1800

E000002

ATC

1.6

12.1

369

2468

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

12.1

458

3215

Z87.6

ICD-10 Finland

Personal history of certain conditions arising in the perinatal period

3.2

12.1

196

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.3

12.0

180

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

18.1

12.0

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

12.0

1288

10820

XCK00

NOMESCO Finland

Perimetry

2.1

11.9

142

706

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

11.9

338

2221

WX872

NOMESCO Finland

Intensive care

2.3

11.9

103

446

AA5HE

NOMESCO Finland

Brain ultrasound examination in a child

3.4

11.8

172

R06.0

ICD-10 Finland

Dyspnoea

1.4

11.8

540

3939

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.4

11.8

102

440

M41.5

ICD-10 Finland

Other secondary scoliosis

11.7

11.8

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.7

11.8

136

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

5.6

11.7

R51.80

ICD-10 Finland

Headache

1.5

11.7

464

3288

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

11.7

110

496

Q79.8

ICD-10 Finland

Other congenital malformations of musculoskeletal system

65.1

11.6

PD5CM

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aorta with 3 Tesla magnet

65.1

11.6

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.0

11.6

229

Q27.88

ICD-10 Finland

Other specified congenital malformation of peripheral vascular system

22.9

11.6

M05BA04

ATC

alendronic acid; oral

2.1

11.5

137

681

B07.9

ICD-10 Finland

Verruca simplex

2.1

11.5

124

594

Q87.28

ICD-10 Finland

Congenital malformation syndromes predominantly involving limbs

+∞

11.5

Q87.03

ICD-10 Finland

Syndrome Goldenhar

+∞

11.5

Q87.5

ICD-10 Finland

Other congenital malformation syndromes with other skeletal changes

+∞

11.5

Q87.1

ICD-10 Finland

Congenital malformation syndromes predominantly associated with short stature

+∞

11.5

7597A

ICD-9 Finland

Other and unspecified congenital anomalies, Multiple congenital anomalies, so described

+∞

11.5

Q87.15

ICD-10 Finland

Prader-Willi syndrome

+∞

11.5

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

3.0

11.4

226

B01AB05

ATC

enoxaparin; parenteral

1.4

11.4

633

4788

J01MA12

ATC

levofloxacin; systemic

1.5

11.4

372

2527

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

11.4

542

3984

301

Kela drug reimbursment

Growth hormone

5.8

11.3

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

3.6

11.2

142

N03AG04

ATC

vigabatrin; oral

8.9

11.2

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

9.6

11.2

L57.0

ICD-10 Finland

Actinic keratosis

2.0

11.2

133

664

R31

ICD-10 Finland

Unspecified haematuria

1.9

11.2

170

931

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

6.2

11.2

L28

ICPC

Limited function/disability (L)

1.6

11.2

299

1939

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

11.1

218

1293

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.5

11.1

143

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

11.1

159

849

C01CA24

ATC

epinephrine; parenteral

1.7

11.1

216

1279

UKC02

NOMESCO Finland

Cystoscopy

1.6

11.1

278

1770

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

11.1

515

3769

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

2.8

11.1

261

F80.1

ICD-10 Finland

Expressive language disorder

3.3

11.0

160

Q25.0

ICD-10 Finland

Patent ductus arteriosus

4.8

10.9

RT150

NOMESCO Finland

5.0

10.9

Z71.8

ICD-10 Finland

Other specified counselling

1.4

10.9

718

5586

R03AC02

ATC

salbutamol; inhalant

1.3

10.8

1531

13285

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

10.8

1596

13925

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

6.5

10.8

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

4.6

10.7

134

Kela drug reimbursment

General erythroderma

10.6

10.7

D36.1

ICD-10 Finland

Benign neoplasm: Peripheral nerves and autonomic nervous system

9.6

10.7

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

10.7

219

QXA40

NOMESCO Finland

Skin laser treatment or photocoagulation, unspecified location

28.1

10.7

R04.0

ICD-10 Finland

Epistaxis

2.0

10.7

142

740

N64.8

ICD-10 Finland

Other specified disorders of breast

5.4

10.7

L81.3

ICD-10 Finland

Café au lait spots

21.5

10.7

WX882

NOMESCO Finland

High dependency care

2.1

10.6

115

552

J01FA10

ATC

azithromycin; systemic

1.3

10.6

1856

16531

ACB19

NOMESCO Finland

Excision of lesion of peripheral nerve other or unspecified

12.9

10.6

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

10.6

119

579

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.0

10.6

193

Q18.0

ICD-10 Finland

Sinus, fistula and cyst of branchial cleft

6.3

10.6

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

10.5

723

5655

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.8

10.5

228

A02BC02

ATC

pantoprazole; systemic

1.3

10.5

1551

13510

E000003

ATC

2.0

10.5

138

714

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.7

10.5

269

Z94.0

ICD-10 Finland

Kidney transplant status

3.5

10.5

140

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

2.1

10.5

111

527

Q87.04

ICD-10 Finland

Syndrome Robin

110.2

10.4

D82.1

ICD-10 Finland

Di George syndrome

110.2

10.4

Q85.83

ICD-10 Finland

Gardner syndrome

110.2

10.4

FCD60

NOMESCO Finland

Resection of thoracoabdominal aorta and reimplantation of branches

+∞

10.4

Q87.84

ICD-10 Finland

Williams syndrome

+∞

10.4

7598X

ICD-9 Finland

Other and unspecified congenital anomalies, Other specified anomalies[ANOMALIAE CONGENITAE ALIAE DEFINITAE]

+∞

10.4

Q85.88

ICD-10 Finland

Other phakomatoses, not elsewhere classified

+∞

10.4

Q87.31

ICD-10 Finland

Syndrome Sotos

+∞

10.4

Q87.38

ICD-10 Finland

Syndrome Weaver

+∞

10.4

Q83.0

ICD-10 Finland

Congenital absence of breast with absent nipple

+∞

10.4

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

5.9

10.4

A11CC03

ATC

alfacalcidol; systemic

2.7

10.4

257

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

8.2

10.3

ZZA00

NOMESCO Finland

Split skin graft

2.8

10.3

229

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

8.8

10.2

D07XC01

ATC

betamethasone, combinations; topical

1.6

10.2

261

1670

J01FA06

ATC

roxithromycin; oral

1.3

10.1

971

7976

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.6

10.1

288

4122

FHL

Tympanostomy (tympanic tube)

2.5

10.1

325

ZX120

NOMESCO Finland

Intravenous

1.7

10.1

220

1350

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

11.3

10.0

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.8

10.0

235

RT490

NOMESCO Finland

8.4

10.0

A06AD11

ATC

lactulose; oral

1.6

10.0

259

1663

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

9.1

10.0

Q67.0

ICD-10 Finland

Facial asymmetry

40.1

10.0

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

9.9

803

6438

ZZR00

NOMESCO Finland

Flap of skin

3.6

9.9

121

Q35.71

ICD-10 Finland

Submucous cleft palate

16.7

9.9

Z51.80

ICD-10 Finland

Manipulation of puberty development with hormone therapy

16.7

9.9

PD5BG

NOMESCO Finland

MRI examination of thoracal and abdominal aortta with high intensity magnet

16.7

9.9

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.8

9.9

164

926

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

2.9

9.8

203

D07AC01

ATC

betamethasone; topical

1.3

9.8

803

6443

B01AA03

ATC

warfarin; systemic

1.6

9.8

280

1843

ENC80

NOMESCO Finland

Plastic operation of soft palate for voice distubance

26.1

9.8

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

4.1

9.8

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

9.8

233

1466

H53.0

ICD-10 Finland

Amblyopia ex anopsia

3.2

9.7

160

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.9

9.7

134

710

N05BA09

ATC

clobazam; oral

3.6

9.7

118

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

9.7

151

833

EHC30

NOMESCO Finland

Reconstruction of palate

55.1

9.6

HA1AA

NOMESCO Finland

X-ray mammography

1.8

9.6

173

1002

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

9.6

230

1449

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

9.6

931

7650

R06AE07

ATC

cetirizine; oral

1.3

9.6

1266

10834

A03FA02

ATC

cisapride; oral, rectal

1.8

9.6

156

874

N03AG01

ATC

valproic acid; systemic, rectal

1.8

9.6

176

1026

RL130

NOMESCO Finland

4.9

9.6

N06AB03

ATC

fluoxetine; oral

1.5

9.5

331

2279

E000006

ATC

1.7

9.5

191

1145

I71.1

ICD-10 Finland

Thoracic aortic aneurysm, ruptured

15.0

9.5

J01MA14

ATC

moxifloxacin; systemic

1.7

9.4

192

1153

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

4.9

9.4

6114A

ICD-9 Finland

Other disorders of breast, Atrophy of breast

17.5

9.4

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

9.4

139

753

Q83

ICD-10 Finland

Congenital malformations of breast

+∞

9.4

75980

ICD-8 Finland

Congenital syndromes affecting multiple systems, Syndroma Marfan, arachnodactylia

+∞

9.4

Q81.1

ICD-10 Finland

Epidermolysis bullosa letalis

+∞

9.4

Q80.3

ICD-10 Finland

Congenital bullous ichthyosiform erythroderma

+∞

9.4

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

3.8

9.4

101

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.8

9.4

154

865

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

9.3

657

5149

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

9.3

282

1883

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.5

9.3

283

R5120

NOMESCO Finland

Preparation of an aid

2.9

9.3

194

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.3

9.3

H50.31

ICD-10 Finland

Intermittent exotropia

3.1

9.2

155

D07AC13

ATC

mometasone; topical

1.3

9.2

701

5557

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

9.2

208

1291

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.3

9.2

373

WX704

NOMESCO Finland

Intubation

1.7

9.2

183

1096

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.7

9.2

103

N06AX21

ATC

duloxetine; oral

1.6

9.1

263

1736

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

3.5

9.1

114

E34.39

ICD-10 Finland

Short stature, not elsewhere classified

4.0

9.1

QAA10

NOMESCO Finland

Incision of skin of head or neck

11.5

9.0

EB1WA

NOMESCO Finland

4.2

9.0

D33.45

ICD-10 Finland

Benign Schwannom in the nerve root of the spinal cord

15.6

9.0

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.8

9.0

209

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.1

9.0

461

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

4.2

9.0

SPAT1229

SPAT

Assessment of need for aid

1.8

8.9

145

812

L04AA06

ATC

mycophenolic acid; systemic

2.7

8.9

223

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

8.9

480

3596

3812A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media

2.5

8.9

277

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

8.9

150

852

H61.2

ICD-10 Finland

Impacted cerumen

1.9

8.8

127

683

Q99.8

ICD-10 Finland

Other specified chromosome abnormalities

7.9

8.8

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

8.8

611

4771

A02BC05

ATC

esomeprazole; systemic

1.3

8.8

919

7611

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

8.6

8.8

I78.9

ICD-10 Finland

Disease of capillaries, unspecified

9.5

8.8

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

8.7

487

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.5

8.7

113

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

4.2

8.7

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

8.7

309

2142

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.5

8.6

251

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

8.6

376

2713

H03AA01

ATC

levothyroxine sodium; systemic

1.4

8.6

537

4129

R03BA02

ATC

budesonide; inhalant

1.4

8.6

466

3498

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

8.6

195

1210

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

8.2

8.6

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.0

8.5

159

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

1.8

8.5

154

896

N62

ICD-10 Finland

Hypertrophy of breast

1.9

8.5

118

627

J01CA04

ATC

amoxicillin; systemic

1.3

8.5

2621

24670

GAE06

NOMESCO Finland

Excision of lesion of chest wall

27.5

8.5

D61.0

ICD-10 Finland

Constitutional aplastic anaemia

20.0

8.5

602

Kela drug reimbursment

Children's severe malnutrition

3.0

8.4

149

FCC50

NOMESCO Finland

Resection and reconstruction of descending aorta using tube graft

90.2

8.4

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.4

8.4

287

Z50.5

ICD-10 Finland

Speech therapy

2.3

8.4

314

N64.9

ICD-10 Finland

Disorder of breast, unspecified

3.4

8.4

112

Q87.82

ICD-10 Finland

Zellweger syndrome

+∞

8.3

7573E

ICD-9 Finland

Congenital anomalies of the integument, Other specified anomalies of skin[URTICARIA PIGMENTOSA (MASTOCYTOSIS)]

+∞

8.3

Q84.8

ICD-10 Finland

Other specified congenital malformations of integument

+∞

8.3

Q85.81

ICD-10 Finland

Sturge-Weber syndrome

+∞

8.3

Q89.00

ICD-10 Finland

Asplenia (congenital)

+∞

8.3

Q87.10

ICD-10 Finland

Aarskog syndrome

+∞

8.3

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

8.3

221

1431

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

2.6

8.3

220

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

8.3

224

1458

C03DA01

ATC

spironolactone; oral

1.7

8.3

181

1115

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

8.3

503

3846

G40.10

ICD-10 Finland

Simple partial seizures

3.9

8.2

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.8

8.2

D07AA02

ATC

hydrocortisone; topical

1.4

8.2

444

3332

NK1AT

NOMESCO Finland

Muscle biopsy with ultrasound guidance

14.5

8.2

L91.0

ICD-10 Finland

Hypertrophic scar

2.7

8.2

205

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

8.1

392

9749

FHL

Other measure in this category

6.0

8.1

XQ800

NOMESCO Finland

Prick test

1.5

8.1

252

1692

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

8.1

228

1495

S29

ICPC

Skin symptom/complaint other

1.4

8.1

401

2959

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

3.3

8.1

115

ICD-10 Finland

2.5

8.1

234

Q24.0

ICD-10 Finland

Dextrocardia

33.4

8.1

F72.0

ICD-10 Finland

Severe mental retardation, with the statement of no, or minimal, impairment of behaviour

17.2

8.1

S06.0

ICD-10 Finland

Concussion

1.5

8.0

280

1928

M41.1

ICD-10 Finland

Juvenile idiopathic scoliosis

3.0

8.0

149

Q16.1

ICD-10 Finland

Congenital absence, atresia and stricture of auditory canal (external)

22.0

8.0

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

8.0

151

889

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

8.0

194

1226

M25.5

ICD-10 Finland

Pain in joint

1.3

8.0

709

5736

A28

ICPC

Limited function/disability NOS

1.5

7.9

235

1563

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

7.9

133

758

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

3.8

7.9

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

2.1

7.9

418

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.1

7.9

444

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

7.9

471

3589

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.4

7.9

259

F70

ICD-10 Finland

Mild mental retardation

13.0

7.9

DFF20

NOMESCO Finland

Audiometry for children

3.5

7.8

102

J01AA02

ATC

doxycycline; systemic

1.2

7.8

1963

17915

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.0

7.8

146

N05BA04

ATC

oxazepam; oral

1.3

7.8

581

4581

TQW80

NOMESCO Finland

Local dermatologic skincare

2.3

7.8

292

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.5

7.8

260

1777

ZX114

NOMESCO Finland

Intramuscular

2.7

7.8

186

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

9.4

7.8

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

7.7

174

1080

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

7.7

159

962

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

3.6

7.7

BF10A

NOMESCO Finland

45.0

7.7

Q35.3

ICD-10 Finland

Cleft soft palate

45.0

7.7

Q82

ICD-10 Finland

Other congenital malformations of skin

45.0

7.7

R3120

NOMESCO Finland

Training in mobility skills

15.0

7.7

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

7.7

408

Q18.8

ICD-10 Finland

Other specified congenital malformations of face and neck

5.9

7.7

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

5.9

7.7

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.9

7.6

107

571

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

7.6

123

692

R62.8

ICD-10 Finland

Other lack of expected normal physiological development

3.9

7.6

Q17.2

ICD-10 Finland

Microtia

25.0

7.6

Q21.21

ICD-10 Finland

Atrioventricular duct

25.0

7.6

B02AA02

ATC

tranexamic acid; systemic

1.4

7.6

372

2741

H65.2

ICD-10 Finland

Chronic serous otitis media

2.8

7.5

161

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

3.3

7.5

111

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

7.5

261

1795

J47

ICD-10 Finland

Bronchiectasis

3.1

7.5

122

9729

FHL

Other measure in this category

8.8

7.5

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

7.5

155

939

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

7.5

1494

13277

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

7.5

129

743

Catheterization and pressure measurement of the right side of the heart

7.1

7.5

XJC10

NOMESCO Finland

Oesophageal pH monitoring

4.0

7.4

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

7.4

257

1771

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

7.4

466

3581

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

7.4

182

1159

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

7.4

214

1415

P94.2

ICD-10 Finland

Congenital hypotonia

13.4

7.4

RT190

NOMESCO Finland

7.6

7.4

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

4.5

7.4

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

7.4

269

1875

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

2.2

7.3

346

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

7.3

842

7033

XKC03

NOMESCO Finland

Water cystometry

2.2

7.3

303

9744

FHL

+∞

7.3

Q81.2

ICD-10 Finland

Epidermolysis bullosa dystrophica

+∞

7.3

Q84.9

ICD-10 Finland

Congenital malformation of integument, unspecified

+∞

7.3

7593A

ICD-9 Finland

Other and unspecified congenital anomalies, Situs inversus

+∞

7.3

Q87.27

ICD-10 Finland

CHARGE association

+∞

7.3

Q81.8

ICD-10 Finland

Other epidermolysis bullosa

+∞

7.3

Q89.20

ICD-10 Finland

Congenital malformation of pituitary gland

+∞

7.3

D48.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue

2.7

7.3

176

Q67.6

ICD-10 Finland

Pectus excavatum

9.4

7.3

Q23.10

ICD-10 Finland

Congenital insufficiency of aortic valve

9.4

7.3

AA6AD

NOMESCO Finland

Cranial bones CT examination

9.4

7.3

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.8

7.2

154

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.6

7.2

184

9734

FHL

Excision and local plastic or associated free skin grafting

5.1

7.2

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

7.2

144

865

QDE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of lower limb

15.7

7.2

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.2

7.2

319

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

7.3

7.2

E34.35

ICD-10 Finland

Abnormal growth retardation

2.9

7.2

141

D33.39

ICD-10 Finland

Benign tumor of the cranial nerves UNS

30.0

7.1

QAE50

NOMESCO Finland

Dermabrasion of superficial lesion of skin of head or neck

30.0

7.1

XF402

NOMESCO Finland

ECG with work load test

1.6

7.1

190

1232

TK800

NOMESCO Finland

Hemodialysis

2.6

7.1

196

WX320

NOMESCO Finland

Spinalanesthesy

1.3

7.1

453

3485

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.8

7.1

L04AA10

ATC

sirolimus; oral

20.0

7.1

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

7.1

325

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

7.1

797

6631

Congenital heart failure surgery

6.6

7.1

N06AX11

ATC

mirtazapine; oral

1.3

7.1

743

6131

C01AA05

ATC

digoxin; systemic

2.0

7.1

460

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.1

7.1

348

C07AB02

ATC

metoprolol; systemic

1.4

7.1

324

2359

D21.1

ICD-10 Finland

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

3.5

7.0

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

7.0

294

2101

L85.89

ICD-10 Finland

Other specified epidermal thickening

8.8

7.0

RK110

NOMESCO Finland

3.8

7.0

L05

ICPC

Flank/axilla symptom/complaint

1.8

7.0

119

680

H52.0

ICD-10 Finland

Hypermetropia

2.2

7.0

308

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.4

7.0

237

ABB00

NOMESCO Finland

Excision of lesion of spinal canal

7.0

Q21.30

ICD-10 Finland

Tetralogy of Fallot

7.0

R03DC03

ATC

montelukast; oral

1.3

7.0

428

3277

UJH02

NOMESCO Finland

Anoscopy

1.9

7.0

470

R03BA01

ATC

beclometasone; inhalant

1.4

7.0

304

2195

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

7.0

102

557

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

6.9

415

3164

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.6

6.9

183

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.1

6.9

358

D11

ICPC

Diarrhoea

1.4

6.9

330

2418

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.8

6.9

107

593

R42

ICD-10 Finland

Dizziness and giddiness

1.3

6.9

427

3270

N06AB04

ATC

citalopram; systemic

1.3

6.9

488

3814

ABB10

NOMESCO Finland

Resection of lesion of spinal canal

13.8

6.9

A90

ICPC

Congenital anomaly NOS/multiple

13.8

6.9

FCA75

NOMESCO Finland

Valve-sparing repair of aortic root (David, Yacoub)

13.8

6.9

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

2.7

6.9

171

N03AX09

ATC

lamotrigine; oral

1.7

6.9

149

918

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

6.9

190

1245

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

2.8

6.8

148

H50.0

ICD-10 Finland

Convergent concomitant strabismus

2.7

6.8

155

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

6.8

163

1031

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.9

6.8

472

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

6.8

304

2203

EB1MA

NOMESCO Finland

Cephalometry with X-ray

1.7

6.8

131

780

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

6.8

502

D33.14

ICD-10 Finland

Hemangioblastoma and cerebellum

40.1

6.8

22550

ICD-8 Finland

Benign neoplasm of brain and other parts of nervous system, Peripheral nerves

40.1

6.8

ZXB10

NOMESCO Finland

Medial

3.6

6.7

EFB40

NOMESCO Finland

Removal of internal or external fixation device from facial bones

5.6

6.7

7151

FHL

Kidney transplantation

16.7

6.7

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

6.7

190

1250

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

6.7

616

4995

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

4.3

6.7

JAH00

NOMESCO Finland

Laparotomy

2.2

6.7

280

C07AA05

ATC

propranolol; systemic

1.3

6.7

498

3924

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

6.7

536

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.4

6.7

211

AB4AE

NOMESCO Finland

Spinal ultrasound examination

22.5

6.7

QB5S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in back

22.5

6.7

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

6.7

210

1416

137

Kela drug reimbursment

Uraemia requiring dialysis

3.3

6.6

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

6.6

150

935

J02AC01

ATC

fluconazole; systemic

1.2

6.6

1095

9505

RS221

NOMESCO Finland

2.4

6.6

213

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

6.6

641

5234

ZQZ00

NOMESCO Finland

Treatment of several skin areas

7.8

6.6

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

6.6

156

984

L04AA01

ATC

[U] ciclosporin; systemic

2.7

6.6

163

K00.40

ICD-10 Finland

Postnatal enamel hypoplasia

2.5

6.6

188

Q27.9

ICD-10 Finland

Congenital malformation of peripheral vascular system, unspecified

12.2

6.6

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

3.0

6.6

118

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

2.9

6.5

134

PD5DG

NOMESCO Finland

Very extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

10.0

6.5

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

6.5

673

5537

D18.1

ICD-10 Finland

Lymphangioma, any site

6.8

6.5

E23.02

ICD-10 Finland

Neurosecretory dysfunction of the growth hormone

6.8

6.5

JDB00

NOMESCO Finland

Gastrostomy

6.8

6.5

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

4.1

6.5

E34.31

ICD-10 Finland

Short stature, prenatal disorder

5.0

6.5

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

6.5

388

F81.9

ICD-10 Finland

Developmental disorder of scholastic skills, unspecified

4.0

6.5

N30.0

ICD-10 Finland

Acute cystitis

1.4

6.5

329

2443

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

6.2

6.4

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

3.8

6.4

TGC00

NOMESCO Finland

Bronchial lavation

2.5

6.4

191

37870

ICD-8 Finland

Other diseases of eye, Subluxatio et luxatio lentis

69.9

6.4

Aortic root """"composite graft""""

69.9

6.4

7595A

ICD-9 Finland

Other and unspecified congenital anomalies, Tuberous sclerosis

69.9

6.4

D33.46

ICD-10 Finland

Benign neurofibroma in the nerve root of the spinal cord

69.9

6.4

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

6.4

188

1248

48609

ICD-8 Finland

Pneumonia, unspecified

2.6

6.4

167

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

6.4

159

1017

L04AA05

ATC

[U] tacrolimus; systemic

14.3

6.4

QCE99

NOMESCO Finland

Other excision or repair of lesion of skin of upper limb

4.7

6.4

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

6.4

283

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.0

6.4

115

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.4

1735

15807

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.6

6.4

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

6.3

212

R53

ICD-10 Finland

Malaise and fatigue

1.3

6.3

488

3863

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.2

6.3

277

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

6.3

467

N03AF01

ATC

carbamazepine; oral, rectal

1.8

6.3

100

560

D17.2

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

2.6

6.3

169

H02AB06

ATC

prednisolone; systemic

1.2

6.3

1104

9629

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.5

6.3

180

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

6.3

233

1628

K00.00

ICD-10 Finland

Hypodontia

2.4

6.3

198

RS231

NOMESCO Finland

11.0

6.3

BF20A

NOMESCO Finland

11.0

6.3

XCD00

NOMESCO Finland

Clinical examination of eye in general anaesthesia

5.5

6.3

O35.2

ICD-10 Finland

Maternal care for (suspected) hereditary disease in fetus

5.5

6.3

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.8

6.3

139

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

3.1

6.3

105

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

6.3

502

N05CF01

ATC

zopiclone; oral

1.3

6.3

631

5174

N06AX16

ATC

venlafaxine; oral

1.4

6.3

361

2733

A02BC03

ATC

lansoprazole; oral

1.3

6.3

565

4569

X22

ICPC

Concern breast appearance fema

18.0

6.3

Q82.86

ICD-10 Finland

Gorlins syndrome

+∞

6.2

NDT40

NOMESCO Finland

Correction of fingeranomaly

+∞

6.2

Q82.52

ICD-10 Finland

Mongolian blue spot

+∞

6.2

Q87.00

ICD-10 Finland

Syndrome Treacher Collins

+∞

6.2

Q89.38

ICD-10 Finland

Another site inversus

+∞

6.2

Q16.0

ICD-10 Finland

Congenital absence of (ear) auricle

+∞

6.2

Q89.21

ICD-10 Finland

Congenital malformation of the thyroid gland

+∞

6.2

Q82.84

ICD-10 Finland

Pseudoxanthoma elasticum

+∞

6.2

Q87.22

ICD-10 Finland

Nail-patella syndrome

+∞

6.2

L85.2

ICD-10 Finland

Keratosis punctata (palmaris et plantaris)

+∞

6.2

Q87.23

ICD-10 Finland

Rubinstein-Taybi syndrome

+∞

6.2

WZC30

NOMESCO Finland

Teaching

1.4

6.2

278

2015

N05BB01

ATC

hydroxyzine; systemic

1.6

6.2

160

1029

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

6.2

141

879

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

6.2

353

R07.1

ICD-10 Finland

Chest pain on breathing

2.7

6.2

140

Q28.8

ICD-10 Finland

Other specified congenital malformations of circulatory system

26.7

6.2

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

2.6

6.2

164

N06AB10

ATC

escitalopram; oral

1.3

6.2

552

4452

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.4

6.2

250

1776

L17

ICPC

Foot/toe symptom/complaint

1.3

6.2

602

4913

H50.30

ICD-10 Finland

Intermittent esotropy

3.1

6.2

101

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.5

6.1

177

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

7.7

6.1

M41.2

ICD-10 Finland

Other idiopathic scoliosis

3.5

6.1

Q76.30

ICD-10 Finland

Hemivertebra fusion or failure of segmentation with scoliosis

12.5

6.1

NFL22

NOMESCO Finland

Myotomy or tenotomy of hip or thigh

12.5

6.1

M54.8

ICD-10 Finland

Other dorsalgia

1.8

6.1

523

Z97.4

ICD-10 Finland

Presence of external hearing-aid

2.1

6.1

315

Q37.1

ICD-10 Finland

Cleft hard palate with unilateral cleft lip

8.6

6.0

R62.9

ICD-10 Finland

Lack of expected normal physiological development, unspecified

8.6

6.0

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.3

6.0

217

-50

ICPC

Medication/prescr/renewal

1.9

6.0

479

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

4.4

6.0

CG2T4

NOMESCO Finland

Topography assessment of cornea

3.3

6.0

D01

ICPC

Abdominal pain/cramps general

1.4

6.0

325

2437

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1764

12760

1.74

56.68

9.7

7.3

mmol/l

1.2

0.83

1550

10953

(3024561) Albumin [Mass/volume] in Serum or Plasma

1533

10704

1.74

55.54

5.8

5.1

g/l

36.4

36.5

0.44

1441

9996

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1629

11601

1.73

54.73

9.6

7.0

mmol/l

1.2

1.34

1528

10640

(3018418) pH of Serum or Plasma

1113

7153

1.80

53.27

5.0

3.8

7.4

0.24

197

1371

(3033658) Prothrombin time (PT) actual/Normal

1079

6973

1.78

50.10

5.1

4.6

89.9

92.9

3.36

1054

6805

(3003458) Phosphate [Moles/volume] in Serum or Plasma

646

3590

1.97

48.16

8.1

7.4

mmol/l

1.1

0.79

617

3385

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1626

11911

1.66

46.68

3.0

2.4

nmol/l

74.3

74.0

0.12

1515

11022

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2515

20598

1.71

46.66

8.1

6.9

u/l

82.2

80.3

1.01

2396

19445

(3001604) Monocytes [#/volume] in Blood

1972

15178

1.65

46.47

7.3

6.5

e9/l

0.6

0.90

1747

13180

(3006315) Basophils [#/volume] in Blood

1976

15220

1.65

46.39

7.3

6.5

e9/l

0.0

0.81

1750

13210

(3013115) Eosinophils [#/volume] in Blood

2025

15739

1.64

45.47

7.7

6.8

e9/l

0.2

0.01

1813

13916

(3022096) Basophils/100 leukocytes in Blood

1824

13857

1.63

44.53

7.4

6.7

0.7

0.53

1733

13042

(3019069) Monocytes/100 leukocytes in Blood

1881

14403

1.63

44.45

7.7

6.8

8.3

0.30

1797

13599

(3006504) Eosinophils/100 leukocytes in Blood

1869

14310

1.62

44.01

7.5

6.6

2.9

0.04

1780

13433

(3019198) Lymphocytes [#/volume] in Blood

2017

15742

1.63

43.85

7.3

6.5

e9/l

2.0

0.70

1822

13990

(3013650) Neutrophils [#/volume] in Blood by Automated count

2167

17287

1.62

42.44

10.1

9.2

e9/l

4.0

3.9

0.69

1935

15088

(3002030) Lymphocytes/100 leukocytes in Blood

1932

14994

1.61

42.38

7.4

6.6

29.5

30.4

3.02

1843

14130

(42870588) Differential panel, method unspecified - Blood

1414

10190

1.63

41.98

7.5

6.8

—

(40768804) Tissue Pathology biopsy report

1507

11095

1.61

40.59

2.2

2.0

—

(3018010) Neutrophils/100 leukocytes in Blood

1898

14779

1.59

40.18

7.2

6.4

55.8

55.1

1.80

1811

13962

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1739

13344

1.58

38.63

6.6

6.1

umol/l

11.8

12.2

0.45

1648

12563

(3002256) Pathology report gross observation

566

3364

1.81

33.22

1.4

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

632

3884

1.76

33.08

2.8

3.2

29.9

29.8

0.10

622

3778

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

693

4384

1.72

32.67

3.4

3.3

ng/l

667.0

469.5

0.50

443

2815

(3002582) Erythrocytes [#/volume] in Urine

1138

8167

1.57

32.28

3.8

3.2

e6/l

200.0

72.0

0.54

894

6154

(3000991) Gas panel - Venous blood

457

2564

1.89

32.19

10.5

9.8

—

(3044889) 12 lead EKG panel

2170

17900

1.52

32.07

3.6

3.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

463

2619

1.88

31.78

4.8

4.7

u/l

238.2

248.3

0.59

451

2500

(3018095) Leukocytes [#/volume] in Urine

1333

9947

1.53

31.54

4.5

3.7

e6/l

90.1

70.9

0.31

959

6667

(3030467) Casts [#/volume] in Urine by Automated count

1057

7509

1.57

31.11

3.8

3.1

e6/l

0.4

0.3

0.24

824

5566

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

561

3391

1.77

30.93

3.1

2.6

22.0

23.2

1.12

487

2952

(3000850) Epithelial cells [#/volume] in Urine

829

5568

1.63

30.84

3.1

2.6

e6/l

8.1

7.1

0.19

741

4879

(3022948) Iron [Moles/volume] in Serum or Plasma

646

4068

1.71

30.79

2.9

2.5

umol/l

13.1

13.9

1.89

607

3788

(40758558) Short blood count panel - Blood

1083

7761

1.56

30.57

7.6

7.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

597

3686

1.74

30.53

2.9

2.5

g/l

2.4

1.05

554

3430

(3032080) INR in Blood by Coagulation assay

1224

9018

1.54

30.46

10.1

7.2

inr

1.2

1.14

355

2801

(3044640) Blood type and Crossmatch panel - Blood

1202

8823

1.54

30.42

2.7

2.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

418

2323

1.90

30.23

9.7

9.8

mmol/l

8.1

7.5

1.43

404

2241

(3019550) Sodium [Moles/volume] in Serum or Plasma

3211

29216

1.81

29.73

18.2

12.5

mmol/l

139.5

139.6

1.53

3152

28415

(3042936) Bacteria identified in Isolate by Culture

589

3654

1.73

29.53

2.3

2.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

556

3406

1.74

29.13

2.1

1.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3214

29295

1.80

28.98

18.3

12.6

mmol/l

3.9

0.04

3147

28415

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

239

1099

2.26

28.84

3.5

4.8

g/l

3.3

0.14

232

1051

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

788

5312

1.61

28.60

3.5

3.2

ng/l

1150.9

1011.5

0.42

686

4401

(3012095) Magnesium [Moles/volume] in Serum or Plasma

635

4053

1.68

28.59

5.8

5.0

mmol/l

0.8

0.41

603

3826

(3023368) Bacteria identified in Blood by Culture

884

6136

1.58

28.32

5.3

4.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1933

15796

1.47

28.24

6.8

4.9

mmol/l

6.2

6.4

3.85

1813

14529

(36304419) Bacteria [Presence] in Urine

1040

7495

1.54

28.18

3.7

3.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1684

13401

1.47

28.14

4.4

4.0

—

(40768443) Skin Pathology biopsy report

227

1039

2.26

27.69

1.3

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

350

1891

1.94

27.46

5.2

4.8

ng/l

90.7

73.5

1.81

322

1707

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

311

1613

2.01

27.45

3.3

3.6

ng/l

152.9

171.4

0.37

283

1439

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

904

6380

1.55

26.68

2.2

mg/l

1.4

1.1

1.33

694

4689

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

973

7006

1.53

26.11

2.5

2.3

mg/l

2.8

0.07

845

6078

(3027945) Reticulocytes/100 erythrocytes in Blood

455

2736

1.76

25.22

3.5

3.7

1.6

1.7

0.33

429

2484

(3002385) Erythrocyte distribution width [Ratio]

2941

26492

1.56

24.21

19.9

14.3

13.6

13.5

4.03

2898

25957

(3026782) Osmolality of Urine

757

5238

1.56

24.06

3.2

2.7

mosm/kgh2o

564.0

550.7

0.68

662

4481

(3015377) Calcium [Moles/volume] in Serum or Plasma

1131

8522

1.47

23.91

3.4

3.1

mmol/l

2.4

0.08

1020

7634

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

673

4544

1.59

23.76

3.1

2.7

e6/l

1.1

1.2

0.03

388

2512

(3021589) Normoblasts [#/volume] in Blood

1686

13746

1.42

23.01

10.6

9.1

e9/l

0.0

0.14

1378

11147

(3003396) Base excess in Arterial blood by calculation

406

2425

1.76

22.94

10.3

8.4

mmol/l

0.4

0.9

1.54

325

1886

(3016502) Oxygen saturation in Arterial blood

371

2159

1.80

22.91

10.6

9.0

96.4

95.8

1.30

356

2083

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

239

1203

2.05

22.85

4.0

5.3

90.5

92.8

0.80

229

1134

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

406

2429

1.75

22.81

10.2

8.4

kpa

5.1

0.05

387

2326

(3027801) Oxygen [Partial pressure] in Arterial blood

405

2428

1.75

22.58

10.2

8.4

kpa

13.6

13.1

0.95

384

2327

(3002032) Base excess in Venous blood by calculation

448

2767

1.70

22.43

6.7

6.2

mmol/l

1.6

0.07

376

2200

(3002173) Hemoglobin [Mass/volume] in Arterial blood

348

1999

1.82

22.43

10.7

9.1

g/l

119.9

123.0

1.94

335

1928

(3005322) IgE [Units/volume] in Serum or Plasma

407

2464

1.73

21.89

1.4

1.3

u/ml

200.9

228.7

0.37

374

2291

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

636

4323

1.57

21.62

3.2

2.9

e6/l

3.2

0.02

351

2291

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

127

501

2.59

21.53

4.0

3.3

nmol/l

23.4

22.0

0.48

121

489

(3013707) Erythrocyte sedimentation rate by Westergren method

2423

21188

1.42

21.43

4.4

3.9

mm/h

10.6

10.0

1.54

2287

19778

(3014576) Chloride [Moles/volume] in Serum or Plasma

453

2845

1.67

21.25

10.9

7.6

mmol/l

105.0

104.7

0.86

443

2787

(3014111) Lactate [Moles/volume] in Serum or Plasma

368

2183

1.76

21.24

11.6

8.4

mmol/l

1.3

1.4

1.34

358

2070

(3036481) Cortisol [Moles/volume] in Serum or Plasma

473

3005

1.66

21.22

2.3

2.2

nmol/l

356.2

367.9

0.61

441

2781

(3036489) Thrombin time

246

1288

1.97

21.06

3.2

3.8

21.8

0.06

226

1131

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

945

7021

1.47

20.95

2.3

2.2

u/l

349.0

238.1

0.69

911

6671

(3021447) Carbon dioxide [Partial pressure] in Venous blood

444

2784

1.68

20.94

6.7

6.2

kpa

5.9

5.8

0.61

438

2708

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

216

1083

2.06

20.87

8.9

10.9

mg/l

1.3

0.60

206

1040

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

229

1175

2.01

20.76

12.8

11.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2199

19019

1.39

19.95

5.0

4.0

e6/l

644.9

1729.1

1.24

214

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1211

9494

1.41

19.79

3.6

3.4

u/l

31.8

31.3

0.12

1147

9070

(3000494) Fungus identified in Specimen by Culture

495

3265

1.60

18.96

1.7

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3242

30269

1.63

18.68

16.5

11.6

mg/l

21.4

0.03

2616

23066

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

559

3815

1.55

18.42

2.3

1.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

4.53

18.41

2.4

3.2

ug/l

103.5

99.5

0.06

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

336

2.78

18.18

2.2

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

320

1907

1.74

18.11

6.8

7.0

mmol/l

23.8

23.9

0.19

308

1779

(3023520) Reticulocytes [#/volume] in Blood

324

1946

1.73

17.83

2.8

3.3

e9/l

71.2

70.4

0.15

235

1406

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

218

1162

1.93

17.71

13.3

11.0

mmol/l

23.7

24.3

1.77

208

1107

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2647

23819

1.40

17.64

4.6

4.0

pmol/l

14.5

0.50

2481

21974

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1215

9680

1.38

17.54

2.0

1.8

pmol/l

97.2

97.8

0.18

653

5116

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

412

2652

1.62

17.39

2.2

1.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

479

3196

1.57

17.39

3.6

umol/l

7.3

7.0

0.17

397

2741

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

365

2.64

17.04

2.3

1.3

nmol/l

0.2

0.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

406

2618

1.62

17.00

2.1

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1042

8137

1.39

16.84

2.8

2.5

u/l

53.6

56.0

1.40

966

7535

(3037467) Urinalysis macro (dipstick) panel - Urine

2268

19975

1.35

16.78

4.9

4.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1742

14764

1.34

16.57

3.4

2.9

ug/l

98.3

86.6

1.15

1641

13905

(3026008) Bacteria identified in Urine by Culture

1008

7876

1.39

16.09

3.1

2.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

313

2.72

16.02

2.1

1.3

nmol/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

882

6757

1.40

15.79

2.7

2.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

184

963

1.96

15.78

1.6

1.9

g/l

1.3

1.4

1.61

151

849

(3021960) Folate [Moles/volume] in Serum or Plasma

715

5278

1.44

15.78

1.6

1.5

nmol/l

20.1

20.6

0.45

635

4621

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

327

2.64

15.25

6.4

8.2

mg/l

10.4

10.7

0.27

301

(3042111) Morphology [Interpretation] in Bone marrow Narrative

334

2.61

15.14

1.6

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2972

27525

1.42

14.91

5.3

4.6

mu/l

2.6

2.1

0.32

2821

25778

(3014007) Fractional oxyhemoglobin in Arterial blood

240

1394

1.77

14.83

13.3

10.3

94.7

94.2

0.82

240

1387

(3015736) pH of Urine

1347

11152

1.33

14.37

3.6

3.1

—

5.9

—

(3018133) Calcium [Moles/volume] in Urine

144

3.43

14.08

2.5

3.2

mmol/l

2.3

2.7

0.69

134

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

386

2571

1.56

14.00

2.8

2.4

u/l

29.1

56.6

0.85

342

2198

(3023323) Follitropin [Units/volume] in Serum or Plasma

350

2292

1.58

13.66

1.7

1.5

iu/l

20.5

23.9

1.12

277

1878

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2831

26121

1.37

13.55

13.9

9.9

ml/min/173m2

91.9

90.3

2.96

2320

20958

(4035726)

324

2106

1.59

13.04

1.5

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

5.61

12.87

1.7

1.4

ug/l

0.5

0.3

0.69

(3035637) Corticotropin [Mass/volume] in Plasma

108

501

2.19

12.86

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

179

3.04

12.80

30.8

39.1

ug/l

7.0

0.06

162

(40768797) Stomach Pathology biopsy report

499

3581

1.45

12.58

1.3

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

1663

14364

1.29

12.36

5.4

4.6

estimate

0.0

0.42

326

2798

(3035350) Ketones [Presence] in Urine by Test strip

1657

14331

1.28

12.09

3.9

3.3

estimate

0.0

1.08

312

2709

(3011397) Hemoglobin [Presence] in Urine by Test strip

852

6735

1.34

12.06

3.7

3.3

—

(3009261) Glucose [Presence] in Urine by Test strip

1672

14491

1.28

11.95

4.0

3.4

estimate

0.0

0.24

324

2727

(40761511) CBC panel - Blood by Automated count

3324

31728

1.52

11.65

14.3

10.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3290

31354

1.49

11.44

11.3

9.1

u/l

25.9

26.0

0.05

3204

30381

(3024980) IgG subclass 4 [Mass/volume] in Serum

108

530

2.07

11.17

1.4

1.6

g/l

0.7

0.08

416

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

257

1647

1.60

10.98

2.1

2.2

ug/l

9.9

6.9

1.50

239

1463

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.50

10.93

1.3

1.4

—

(3045142) Bone marrow Pathology biopsy report

290

2.44

10.88

1.5

1.4

—

(3022229) Phosphate [Moles/volume] in Urine

3.64

10.76

2.2

3.3

mmol/l

24.0

19.4

0.73

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

366

2550

1.48

10.68

2.8

g/l

0.2

0.06

344

2409

(3022217) INR in Platelet poor plasma by Coagulation assay

347

2392

1.50

10.68

27.6

19.1

inr

1.4

1.2

1.09

361

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

312

2.37

10.60

3.3

2.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

227

1425

1.63

10.56

2.0

1.6

u/l

8.9

0.00

161

1100

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

326

2.33

10.49

3.8

3.0

e6/l

558.9

559.3

0.00

254

(4062490)

345

2.29

10.48

1.3

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

320

2.34

10.47

3.8

3.0

e9/l

0.2

0.79

254

(3005719) IgG [Mass/volume] in Serum or Plasma

346

2397

1.49

10.39

3.2

2.9

g/l

10.1

10.2

0.05

324

2227

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

547

4124

1.38

10.32

2.8

2.7

mmol/l

2.4

0.14

475

3596

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

325

2.30

10.12

1.7

1.4

pmol/l

394.6

366.9

0.16

255

(3011412) CD3 cells [#/volume] in Blood

390

2.18

10.06

3.9

2.9

e9/l

1.3

0.05

233

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.62

9.98

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

125

676

1.88

9.83

5.6

7.7

u/ml

0.4

0.3

0.12

386

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

137

763

1.83

9.82

2.2

2.7

ug/l

485.5

404.3

0.31

131

704

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

330

2.27

9.78

3.2

2.8

12.1

10.9

0.43

226

(3003338) MCHC [Mass/volume]

2927

27530

1.31

9.56

20.8

14.6

g/l

332.5

333.2

3.88

2911

27310

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

289

1964

1.51

9.52

2.6

2.4

ml/min/173m2

71.3

74.5

0.56

123

734

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

302

2073

1.50

9.48

3.4

3.3

pmol/l

4.7

4.6

0.47

281

1860

(3028192) IgG subclass 2 [Mass/volume] in Serum

341

2.22

9.48

1.3

1.4

g/l

3.0

2.7

0.95

250

(3024139) IgG subclass 3 [Mass/volume] in Serum

341

2.22

9.48

1.3

1.4

g/l

0.4

0.83

247

(3024928) Oxygen saturation in Venous blood

105

543

1.96

9.45

8.3

6.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

342

2.22

9.41

1.3

1.4

g/l

6.6

6.3

0.55

251

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2617

24281

1.27

9.40

5.0

4.6

mmol/mol

37.6

38.3

3.83

2482

22821

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.50

9.32

1.2

1.1

65.7

78.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

118

640

1.87

9.22

5.6

4.9

mmol/l

24.5

24.4

0.09

104

581

(3026493) Urate [Moles/volume] in Serum or Plasma

780

6303

1.30

9.11

2.9

2.6

umol/l

3516.5

3908.6

0.12

706

5597

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

474

2.01

9.10

4.2

3.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

322

2261

1.46

9.03

9.2

6.8

kpa

5.2

5.1

1.24

301

2145

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

130

732

1.80

9.02

1.7

1.6

—

(3024731) MCV [Entitic volume]

3523

34301

1.74

8.85

23.8

17.0

89.8

89.7

0.27

3501

33894

(3003181) Sodium [Moles/volume] in Urine

404

2.08

8.85

2.3

2.0

mmol/l

84.5

67.8

1.70

350

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

314

2206

1.46

8.78

9.2

6.9

mmol/l

1.6

1.3

1.04

226

1617

(3009343) pH of Capillary blood

319

2248

1.46

8.78

9.2

6.8

7.4

0.01

194

(3010813) Leukocytes [#/volume] in Blood

3524

34319

1.74

8.77

23.9

17.1

e9/l

6.8

6.7

1.18

3459

33380

(3019309) Folate [Moles/volume] in Red Blood Cells

502

3828

1.36

8.75

1.8

1.7

nmol/l

1156.2

1177.5

0.15

387

2942

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

100

523

1.94

8.74

6.0

u/ml

389.7

1106.0

—

(3026361) Erythrocytes [#/volume] in Blood

3523

34309

1.74

8.73

23.9

17.0

e12/l

4.5

3.70

3455

33372

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

254

1712

1.52

8.71

2.1

1.7

—

(21494434) Karyotype in Bone marrow

227

2.44

8.69

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

116

639

1.84

8.65

1.8

2.4

g/l

10.3

0.00

552

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

204

1312

1.59

8.63

1.7

1.6

—

(3000963) Hemoglobin [Mass/volume] in Blood

3523

34322

1.73

8.54

24.1

17.1

g/l

134.0

135.3

7.15

3501

33912

(3000060) B lymphocytes [#/volume] in Blood

217

2.46

8.52

3.2

3.1

e6/l

332.3

300.1

0.17

134

(3007461) Platelets [#/volume] in Blood

3519

34275

1.71

8.51

23.9

17.1

e9/l

259.8

261.2

0.58

3460

33416

(3035941) MCH [Entitic mass]

3521

34304

1.71

8.44

23.8

17.0

29.9

30.0

0.42

3499

33897

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

294

2.23

8.36

3.5

2.8

e6/l

730.6

796.7

0.16

(3030981) Hyaline casts [#/volume] in Urine by Automated count

187

1188

1.60

8.33

2.7

2.8

e6/l

0.3

0.2

0.43

179

1148

(40760892) CBC W Ordered Manual Differential panel - Blood

854

7052

1.27

8.33

4.9

4.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

165

1019

1.65

8.24

1.7

1.8

g/l

1.1

1.2

0.44

159

962

(1616796) Gas panel - Central venous blood

101

542

1.89

8.20

4.8

3.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

896

7455

1.27

8.19

1.6

1.5

g/l

2.1

0.16

526

4516

(3019060) Gas panel - Arterial blood

202

1313

1.57

8.17

5.6

5.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

161

991

1.65

8.15

1.7

1.8

g/l

0.2

0.41

156

937

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

122

696

1.78

8.14

1.8

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

122

696

1.78

8.14

1.8

2.3

g/l

7.0

7.3

1.63

538

(3009542) Hematocrit [Volume Fraction] of Blood

3091

29455

1.32

8.03

18.4

12.7

39.7

40.0

1.54

2496

23635

(3020630) Protein [Mass/volume] in Serum or Plasma

243

1652

1.50

8.01

2.2

2.7

g/l

66.4

66.9

0.35

228

1536

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

116

656

1.79

7.97

9.7

7.3

iu/ml

446.0

371.7

0.09

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

120

686

1.77

7.95

2.2

1.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

271

1893

1.46

7.82

2.5

2.1

nmol/l

11.0

11.6

0.48

237

1655

(3028626) Oxygen [Partial pressure] in Capillary blood

208

1376

1.54

7.80

11.3

8.2

kpa

9.1

9.3

1.33

200

1311

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.98

7.60

1.3

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

696

1.75

7.59

1.8

2.3

g/l

3.7

3.8

0.48

509

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

146

2.69

7.55

2.8

2.3

ng/l

137.2

145.9

0.12

116

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

110

623

1.79

7.54

2.6

2.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

192

1260

1.55

7.47

1.9

2.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

115

662

1.76

7.47

1.7

2.3

g/l

3.1

0.04

522

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

127

752

1.71

7.47

1.7

1.5

nmol/l

0.6

0.4

0.36

103

604

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

460

1.91

7.42

1.8

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

510

1.86

7.41

2.0

3.6

mg/l

40.6

65.4

0.95

413

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

311

2.11

7.32

1.2

1.3

—

36.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

264

1867

1.45

7.15

1.9

1.8

g/l

1.4

1.3

0.27

253

1748

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

511

1.84

7.06

2.0

3.6

mg/l

88.8

39.6

0.38

415

(3009508) Creatinine [Moles/volume] in Urine

910

7702

1.24

7.00

3.4

3.5

mmol/l

8.1

7.9

0.92

826

6685

(3008152) Bicarbonate [Moles/volume] in Arterial blood

192

1280

1.53

6.98

7.8

7.3

mmol/l

24.8

24.4

0.86

178

1192

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

104

594

1.77

6.96

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

104

594

1.77

6.96

1.5

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

499

1.84

6.96

2.0

3.6

ratio

1.0

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

110

639

1.74

6.95

1.5

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

136

2.66

6.88

1.2

1.1

86.1

92.2

0.35

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

131

802

1.66

6.83

6.0

6.1

1.7

0.22

121

746

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

327

2423

1.38

6.80

3.5

2.9

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

173

2.44

6.74

3.0

2.7

umol/l

56.5

53.6

0.29

152

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

3.63

6.73

3.7

mg/l

89.4

18.7

—

(3047181) Lactate [Moles/volume] in Blood

115

683

1.70

6.72

6.5

7.0

mmol/l

1.3

1.2

0.32

107

591

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

990

8488

1.23

6.70

1.4

u/ml

1.6

1.8

0.15

233

2172

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

212

1456

1.48

6.69

1.7

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2804

26561

1.24

6.63

4.1

3.7

mmol/l

5.7

0.21

2602

24595

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

372

1.95

6.61

1.7

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

116

694

1.69

6.61

2.3

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

988

8486

1.22

6.54

3.3

3.0

ng/l

24.9

42.1

1.89

551

4697

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

134

2.63

6.53

1.1

1.2

g/l

0.3

0.03

109

(21494815) CD4 cells/100 lymphocytes in Specimen

353

1.97

6.52

3.9

2.9

35.5

44.9

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

547

1.77

6.50

1.7

2.3

g/l

39.4

38.3

1.04

483

(44790047)

405

1.89

6.38

2.1

1.8

—

(44790049)

405

1.89

6.38

2.1

1.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

130

2.63

6.37

1.4

1.2

80.2

90.2

0.63

(3044290) Cell count panel - Cerebral spinal fluid

118

717

1.67

6.36

1.4

2.2

—

(44790048)

406

1.89

6.34

2.1

1.8

—

(44806118)

406

1.89

6.34

2.1

1.8

—

(3022313) Gas panel - Capillary blood

250

1791

1.42

6.34

9.5

7.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

129

803

1.63

6.33

6.1

6.2

0.9

0.30

119

747

(3039000) Anion gap in Blood

457

1.83

6.30

7.7

8.8

mmol/l

11.1

11.3

0.14

407

(3018572) Chloride [Moles/volume] in Blood

458

1.83

6.26

7.8

8.8

mmol/l

105.4

105.5

0.07

408

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.84

6.24

1.7

1.8

mg/l

0.8

1.0

0.17

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.84

6.24

1.7

1.8

mg/l

1.0

1.3

0.20

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.84

6.24

1.7

1.8

mg/l

3.9

4.2

0.06

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

339

1.96

6.19

1.8

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

102

602

1.71

6.13

2.0

2.5

g/l

0.5

0.8

0.42

538

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.76

6.07

1.7

1.8

mg/l

0.8

1.4

0.54

(3023419) Bacteria identified in Sputum by Culture

274

2.06

6.01

5.5

3.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

561

1.73

5.99

2.1

1.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

376

2905

1.33

5.97

1.5

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

547

1.74

5.96

4.5

4.4

kpa

9.2

9.0

0.42

541

(3021387) Prolactin [Units/volume] in Serum or Plasma

253

1839

1.40

5.92

1.8

1.6

mu/l

346.4

305.1

1.05

227

1645

(3012501) Base excess in Blood by calculation

548

1.73

5.92

4.5

mmol/l

2.8

2.4

0.77

338

(3013290) Carbon dioxide [Partial pressure] in Blood

549

1.73

5.88

4.5

kpa

5.0

0.02

543

(3000570) Elastase.pancreatic [Mass/mass] in Stool

118

734

1.63

5.83

1.4

ug/g

303.1

315.4

0.26

392

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

122

766

1.61

5.81

1.5

2.2

e6/l

25.5

21.6

0.10

581

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

122

766

1.61

5.81

1.6

2.2

e6/l

1660.1

6108.9

0.42

608

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

100

601

1.68

5.66

4.5

3.7

57.0

55.9

0.46

100

601

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

423

1.81

5.62

1.8

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

5.89

5.62

1.1

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.54

5.59

1.2

2.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

468

1.77

5.58

4.5

5.5

umol/l

400.2

380.3

0.60

420

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

319

1.93

5.47

1.7

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

555

4568

1.25

5.37

2.5

2.6

ug/g

101.9

111.0

0.39

453

3636

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

371

1.85

5.37

1.3

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

587

1.67

5.37

3.4

3.5

e9/l

3.9

0.06

587

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2171

20269

1.17

5.19

3.3

3.1

u/l

42.8

39.0

1.35

2071

19265

(3052851) Hemolysis interference index of Serum or Plasma

126

824

1.55

5.09

3.0

3.2

—

(3019150) Specific gravity of Urine by Refractometry

740

6327

1.21

4.97

3.9

3.5

kg/l

1.0

0.06

101

966

(3010375) cycloSPORINE [Mass/volume] in Blood

186

2.16

4.95

27.1

30.1

ug/l

98.8

134.6

3.29

160

(3024263) Appearance of Synovial fluid

111

2.53

4.94

1.9

2.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

800

6894

1.20

4.94

1.7

1.6

mmol/l

1.4

0.72

714

5967

(3021901) Oxygen saturation in Capillary blood

426

1.75

4.93

4.1

3.5

—

(3044941) Cell count panel - Synovial fluid

360

1.82

4.93

1.6

1.5

—

(3010421) pH of Blood

104

658

1.60

4.86

4.3

7.4

0.22

542

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

256

1930

1.35

4.83

4.7

3.7

mmol/l

1.2

0.56

233

1677

(3037121) Protein [Mass/volume] in Urine

148

1015

1.48

4.80

3.6

4.6

g/l

0.2

0.3

1.50

525

(36660697) Celiac disease serology panel - Serum

395

3170

1.27

4.73

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

237

1.99

4.73

1.2

1.1

u/l

69.1

93.1

0.63

163

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

110

711

1.56

4.71

3.4

3.5

u/ml

5880.5

2022.2

0.29

610

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

127

2.37

4.63

1.4

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

565

1.62

4.61

2.5

2.3

g/l

132.0

132.5

0.06

431

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

257

1957

1.34

4.55

3.3

4.1

ug/l

10.4

18.7

0.66

178

1517

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

116

768

1.53

4.48

2.3

2.1

ug/l

1.7

0.01

103

688

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

229

1721

1.35

4.43

10.3

7.3

mmol/l

24.4

0.23

220

1656

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

257

1.92

4.43

1.7

2.2

32.2

31.9

0.14

257

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

449

1.68

4.39

1.7

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

389

1.73

4.38

2.0

3.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

405

1.72

4.34

1.2

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

513

1.63

4.31

2.2

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

863

7572

1.18

4.29

4.3

3.6

estimate

0.0

0.44

317

2722

(3000475) Leukocytes [#/volume] in Synovial fluid

531

1.61

4.23

1.6

1.7

e6/l

7755.3

12666.8

1.04

393

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

159

2.15

4.20

2.5

1.8

nmol/l

0.1

0.2

0.37

112

(3011648) Oxygen content in Venous blood

242

1.91

4.14

15.2

9.0

11.1

11.3

0.16

242

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

125

856

1.48

4.13

1.8

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

215

1.96

4.09

2.1

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

215

1.96

4.09

2.1

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

215

1.96

4.09

2.1

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

498

1.62

4.06

3.1

2.5

17.0

16.9

0.13

259

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

111

2.35

3.98

1.7

2.1

nmol/l

3.4

4.2

0.57

106

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.48

3.95

2.5

2.3

umol/l

24.4

17.0

1.39

(3020682) Albumin/Creatinine [Ratio] in Urine

726

6337

1.18

3.80

4.2

4.1

mg/mmol

8.4

11.8

0.58

512

4112

(3003694) ABO and Rh group [Type] in Blood

1076

9691

1.16

3.77

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.92

3.73

3.3

2.0

—

(3013512) EKG study

730

6390

1.18

3.69

3.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

6.67

3.67

1.0

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

135

2.16

3.66

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

286

2283

1.27

3.62

5.2

4.3

1.1

0.8

0.69

601

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

190

1.96

3.61

6.4

4.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

532

1.55

3.54

1.3

u/ml

1.4

4.2

2.92

182

(3025159) Blasts/100 leukocytes in Blood

262

2075

1.28

3.54

5.4

4.5

0.1

0.4

0.71

471

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.51

3.53

2.0

2.7

—

(4010399)

232

1809

1.30

3.53

1.7

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

470

1.59

3.50

1.2

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

578

4983

1.19

3.49

1.6

pmol/l

38057115.2

37661852.9

0.01

494

4259

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

115

804

1.44

3.47

1.6

1.3

ug/l

5.4

4.1

0.43

106

750

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

165

1228

1.36

3.47

1.5

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

273

2180

1.27

3.46

5.3

4.4

0.2

0.1

0.45

555

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

356

1.67

3.43

2.1

1.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

410

1.62

3.43

1.7

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

214

1658

1.31

3.42

1.9

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

131

941

1.41

3.41

6.0

4.2

52.9

51.1

0.34

131

926

(3012516) Albumin [Mass/volume] in Urine

691

6062

1.17

3.39

3.6

3.4

mg/l

809.0

368.1

1.12

497

3916

(3052592) Norovirus Ag [Presence] in Stool

3.10

3.36

1.1

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

283

1.74

3.34

1.2

1.3

u/ml

2.6

0.6

0.46

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

298

1.72

3.34

1.9

1.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.25

3.33

2.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

594

5155

1.18

3.32

1.3

iu/ml

37.1

27.2

0.60

188

1552

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

314

1.70

3.31

2.0

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

128

923

1.40

3.28

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

160

1198

1.35

3.25

1.2

1.3

u/ml

0.3

1.0

1.51

(3022145) Colonoscopy Study observation

348

2878

1.23

3.25

1.4

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

505

1.53

3.20

2.4

2.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

178

1.92

3.18

2.8

2.7

35.8

43.9

1.28

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1207

11063

1.13

3.17

4.0

3.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

531

1.52

3.16

1.9

pmol/l

171.5

194.5

1.20

501

(3016018) Differential panel - Cerebral spinal fluid

388

1.61

3.15

1.7

2.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

267

1.73

3.11

1.5

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

519

1.51

3.05

1.3

u/ml

3.1

4.8

1.03

216

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

125

910

1.39

3.05

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

157

1185

1.34

3.05

2.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

160

1.94

3.03

2.3

2.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

160

1.94

3.03

2.3

2.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

385

1.59

3.01

1.6

1.3

—

(3037756) Immunofixation for Serum or Plasma

362

1.61

3.00

1.3

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

324

2684

1.23

2.99

1.3

1.2

iu/ml

116.8

155.1

1.15

114

987

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

154

1163

1.34

2.99

2.0

u/l

38.6

39.3

0.16

143

1068

(42529406) Shigella sp [Presence] in Stool by Culture

127

932

1.37

2.96

1.2

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

972

8823

1.14

2.93

1.8

1.7

—

(40768446) Kidney Pathology biopsy report

148

1.97

2.93

1.8

2.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

259

2101

1.25

2.91

5.1

4.1

0.7

0.6

0.32

440

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

177

1.87

2.90

2.0

1.7

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

206

1.80

2.89

2.8

4.0

ug/l

1.8

1.6

0.28

197

(3001964) Herpes simplex virus Ag [Presence] in Specimen

108

2.14

2.89

2.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.70

2.88

1.0

1.1

umol/24h

0.5

0.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

167

1284

1.31

2.87

1.5

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

6.67

2.86

1.3

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.50

2.86

1.8

2.9

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

118

863

1.38

2.83

1.8

1.6

—

20.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

116

2.07

2.81

1.1

u/l

37.7

21.4

0.52

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

246

1.71

2.78

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

117

2.06

2.76

1.1

u/l

120.7

81.2

0.61

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

371

1.57

2.74

2.0

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2577

24825

1.13

2.74

3.7

3.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.31

2.74

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

181

1.83

2.72

1.8

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

529

4624

1.17

2.71

1.8

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

125

2.01

2.69

1.5

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

204

1.77

2.68

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

112

2.06

2.66

1.7

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

536

1.46

2.66

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

111

814

1.37

2.64

1.8

1.7

nmol/l

42.3

40.1

0.29

111

797

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.16

2.60

7.3

8.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

153

1182

1.31

2.58

1.7

—

(21494755) Public health laboratory ask at order entry panel

326

3840

0.83

2.55

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

276

2290

1.22

2.55

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

616

1.42

2.54

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

235

1918

1.24

2.53

1.3

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2716

26295

1.13

2.50

3.8

3.4

mmol/l

1.3

1.2

0.16

2563

24656

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

115

2.00

2.50

1.7

1.3

—

(3000012) Reticulocyte production index

115

2.00

2.50

1.6

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

712

6397

1.14

2.49

1.5

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.32

2.47

1.6

nmol/l

22.1

14.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

214

1734

1.25

2.47

1.5

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

110

816

1.36

2.46

1.9

1.7

u/ml

116.9

108.6

0.32

132

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.29

2.40

3.3

5.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

289

2427

1.21

2.37

2.7

2.3

u/l

3490.3

6400.4

1.46

121

940

(3028433) Virus identified in Specimen by Culture

125

1.92

2.34

1.0

1.3

—

(3025941) Bacteria identified in Stool by Culture

222

1818

1.23

2.34

1.3

1.2

—

(40761536) Microorganisms panel - Urine sediment

304

2570

1.20

2.33

4.7

3.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

162

1281

1.28

2.32

1.7

1.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

628

1.39

2.31

3.3

umol/l

33.1

33.7

0.13

557

(3020891) Body temperature

114

861

1.33

2.29

8.0

4.9

—

(3042631) Mycobacterium sp identified in Specimen

238

1.64

2.28

2.8

3.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

208

1.69

2.26

1.3

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

522

1.43

2.25

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

209

1.68

2.22

3.4

2.4

—

(3000492) Spirometry study

339

2910

1.18

2.20

1.7

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

150

1.80

2.19

1.1

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

128

991

1.30

2.17

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

134

1044

1.29

2.17

1.1

u/ml

2.9

5.5

0.97

166

(3042733) HLA Ab [Presence] in Serum

136

1.84

2.17

5.6

4.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

961

8862

1.11

2.16

2.1

2.0

—

(3037522) Nuclear Ab [Titer] in Serum

487

4313

1.15

2.11

1.4

titre

514.6

520.5

0.02

822

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.05

2.10

1.9

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.05

2.10

1.9

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

116

1.90

2.10

1.1

—

(3017704) Immunofixation for Urine

102

1.96

2.09

1.3

1.8

—

(3022621) pH of Urine by Test strip

213

1762

1.22

2.07

2.7

2.6

—

(4146454)

207

0.43

2.06

2.9

2.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

101

763

1.33

2.05

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

117

1.88

2.05

1.9

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

112

860

1.31

2.04

1.4

1.2

—

(1002224) Polysomnography panel

160

1286

1.25

2.03

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

424

1.44

2.03

1.7

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

879

8094

1.11

2.02

3.5

2.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

123

958

1.29

2.02

1.6

1.5

u/ml

242.3

232.8

0.14

536

(3048879) Bone marrow aspiration report

2.40

2.02

1.9

2.3

—

(4306422)

517

1.40

2.01

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

118

1.87

2.01

1.9

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.00

1.99

1.1

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

133

1.81

1.98

1.9

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

156

1.73

1.95

1.1

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

4.55

1.94

1.0

4.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

338

1.48

1.93

1.2

u/l

64.6

39.7

0.24

290

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.73

1.93

1.7

1.9

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.73

1.93

1.0

1.2

umol/24h

1.6

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

109

842

1.30

1.92

2.5

2.0

iu/l

5.1

4.3

0.32

319

(3025130) Human papilloma virus identified in Specimen

548

1.38

1.91

1.7

1.8

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.05

1.90

2.1

2.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

165

1.70

1.90

5.2

6.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

142

1136

1.26

1.90

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

106

1.89

1.90

2.9

2.3

—

(3049717) Cytology report of Urine Cyto stain

626

1.35

1.89

2.3

2.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2851

27815

1.11

1.88

4.5

4.0

mmol/l

2.8

0.79

2698

26060

(3006922) Hepatitis E virus Ab [Presence] in Serum

212

1.61

1.87

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

542

4875

1.13

1.87

1.3

u/ml

6.8

9.8

0.75

204

1970

(3000093) Morphology [Interpretation] in Blood Narrative

237

1.57

1.83

1.3

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

544

1.37

1.83

1.1

—

(40768793) Breast Pathology biopsy report

630

1.34

1.83

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

104

805

1.30

1.82

1.2

1.4

titre

203.6

79.4

0.55

(40761535) Cells panel - Urine sediment

230

1945

1.19

1.81

3.9

3.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

580

1.35

1.80

1.5

1.4

—

(40768795) Lymph node Pathology biopsy report

239

1.55

1.78

1.4

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

127

1012

1.26

1.78

1.4

1.2

—

(3001729) Color of Synovial fluid

3.33

1.74

3.2

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2824

27570

1.10

1.74

4.2

3.7

mmol/l

4.6

4.7

3.03

2693

26031

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

193

1614

1.21

1.73

2.1

2.7

u/ml

25.8

45.1

3.17

187

1556

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

314

1.47

1.72

4.1

4.2

u/ml

23.0

79.8

1.36

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

140

1.72

1.71

1.0

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

440

1.39

1.71

1.1

—

(4268621)

348

1.44

1.70

2.6

2.4

—

(3023410) Appearance of Cerebral spinal fluid

415

1.40

1.70

1.7

2.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.29

1.70

1.1

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

103

806

1.28

1.68

1.1

u/ml

12.7

5.3

0.61

356

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

308

1.47

1.67

1.1

mg/l

181.1

225.1

2.10

264

(3010144) Erythrocytes [#/volume] in Synovial fluid

211

1.57

1.67

1.6

1.4

e6/l

61473.8

97717.9

0.25

148

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

161

1330

1.22

1.65

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.98

1.63

1.7

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

285

1.48

1.63

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

565

1.33

1.62

3.7

3.2

mg/l

17.6

22.7

1.04

353

(3022725) Serotonin [Moles/volume] in Serum

3.57

1.61

1.0

1.5

nmol/l

1965.8

1964.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

229

1961

1.18

1.60

1.3

au/ml

28.5

41.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.50

1.59

2.1

2.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.00

1.58

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

264

1.48

1.55

2.8

2.1

mg/l

18.0

25.8

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.11

1.54

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2800

27373

1.09

1.54

4.0

3.7

mmol/l

1.5

2.35

2651

25720

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

424

1.37

1.53

4.0

3.4

u/ml

27.8

15.9

0.30

382

(3049233) Organic acids panel - Urine

2.27

1.53

1.1

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

193

2261

0.84

1.51

1.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.00

1.48

1.5

2.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

506

4603

1.11

1.47

3.8

4.3

ug/l

1.8

2.3

1.33

467

4141

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

285

3231

0.87

1.46

1.6

—

(44813793)

301

1.43

1.46

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

301

1.43

1.46

1.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

171

1.58

1.45

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

203

1.53

1.45

1.0

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

246

2139

1.16

1.44

2.3

2.4

au/ml

24.8

22.3

0.11

154

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

466

4225

1.12

1.44

1.9

1.7

1.4

0.01

426

3795

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

406

3652

1.12

1.44

3.7

3.8

24.1

21.3

1.86

153

1563

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

134

1105

1.22

1.43

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.79

1.42

5.6

3.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

286

1.44

1.42

1.2

1.1

—

(3034426) Prothrombin time (PT)

118

1.70

1.40

1.2

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

321

1.41

1.39

1.1

1.2

mg/l

26.0

36.7

2.29

259

(4027681)

263

1.45

1.38

1.2

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

236

2055

1.16

1.37

1.1

1.2

titre

66.4

227.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

158

1.58

1.37

5.6

3.3

umol/l

102.6

116.9

—

(3050794) Legionella sp Ab [Presence] in Serum

2.61

1.36

1.0

—

(3017509) Phencyclidine [Presence] in Urine

2.14

1.33

1.8

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

745

1.25

1.32

1.1

u/ml

5.8

6.8

0.25

349

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

360

1.36

1.29

1.0

1.1

—

(3019977) pH of Arterial blood

106

1.70

1.29

1.4

3.5

7.4

—

(3017732) Neutrophils [#/volume] in Blood

236

2070

1.15

1.26

2.8

2.5

e9/l

4.2

4.1

0.08

206

1720

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

107

876

1.23

1.26

2.2

1.8

—

(3045414) Leukocytes [Presence] in Urine

146

1235

1.19

1.23

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

123

1.63

1.23

3.0

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

123

1.63

1.23

3.0

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

123

1.63

1.23

3.0

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

123

1.63

1.23

2.9

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

228

1.45

1.23

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

100

1.70

1.23

2.6

2.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.63

1.21

13.8

4.6

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

2.63

1.21

1.2

mg/l

0.6

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.80

1.20

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

370

3353

1.11

1.18

1.9

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

197

1.47

1.18

1.7

1.5

35.2

34.7

0.02

123

(3043410) Blood group antigens tested for on Red Blood Cells

1.75

1.18

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

586

1.27

1.18

1.7

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

118

984

1.20

1.17

2.6

1.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

123

1031

1.20

1.16

1.1

u/ml

1.6

3.3

1.07

300

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

758

7114

1.08

1.15

1.8

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.81

1.14

3.6

6.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

509

1.28

1.14

4.6

3.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

281

3130

0.89

1.14

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

199

1.46

1.14

1.0

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

191

1.47

1.13

1.1

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

139

1182

1.18

1.13

1.1

1.2

u/ml

3.3

2.0

0.51

591

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.33

1.12

1.1

1.6

ng/l

63.1

95.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

217

1.43

1.10

1.0

1.1

ratio

1.0

0.04

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

673

1.24

1.10

1.1

u/ml

0.9

0.4

0.32

205

(4038314)

2.38

1.09

1.0

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

144

1.53

1.08

2.3

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

120

1.59

1.08

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

177

1.47

1.07

1.9

1.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

278

1.37

1.07

3.7

3.1

nmol/l

0.8

0.28

213

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

202

1.44

1.07

1.1

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

123

1041

1.19

1.07

1.1

u/ml

1.3

1.2

0.11

556

(3043409) Potassium [Moles/volume] in Arterial blood

631

1.24

1.06

5.5

3.9

mmol/l

3.9

3.8

0.47

589

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

186

1.45

1.05

1.9

1.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.12

1.05

1.7

2.5

—

(3024471) HLA-A [Type]

145

1.52

1.05

1.0

—

(3005033) Fetal Nuchal fold Thickness US

109

1292

0.84

1.05

1.5

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

203

1.43

1.04

1.1

1.0

—

(3045424) Erythrocytes [Presence] in Urine

445

1.28

1.04

1.4

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

128

1494

0.85

1.03

1.5

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

146

1.51

1.02

1.5

u/l

3.0

5.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.83

1.02

1.1

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.73

1.02

3.8

2.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

110

1296

0.84

1.00

1.5

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

325

1.33

1.00

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

113

1327

0.85

0.99

1.6

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

257

1.36

0.98

1.1

1.5

promille

1.8

1.3

0.80

207

(3034274) Bile acid [Moles/volume] in Serum --fasting

794

1.20

0.97

3.0

umol/l

9.9

7.2

0.75

606

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

139

1601

0.86

0.96

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

139

1598

0.86

0.94

1.5

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

1.78

0.94

3.6

10.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.61

0.93

1.2

1.5

nmol/l

85.6

116.9

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

140

1606

0.87

0.93

1.5

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

321

1.31

0.92

1.5

1.4

mmol/l

9.9

11.7

0.79

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

140

1605

0.87

0.92

1.5

1.4

—

(3019225) pH of Specimen

248

2236

1.12

0.92

4.4

3.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

790

1.19

0.91

1.4

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.14

0.91

8.5

8.6

mmol/l

5.7

6.0

—

(3006576) Bicarbonate [Moles/volume] in Blood

1.63

0.90

5.8

8.1

mmol/l

25.0

24.8

0.05

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

718

1.20

0.90

1.1

au/ml

4.5

14.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

125

1079

1.16

0.89

1.1

u/ml

4.2

6.2

0.88

658

(40757373) Influenza virus identified in Isolate

1.91

0.88

2.1

2.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

154

1747

0.88

1.6

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

127

0.55

0.88

1.6

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.65

0.87

3.6

6.7

—

(3024932) HLA-DR beta [Type]

144

1.46

0.86

1.1

—

(4198724)

246

1.34

0.86

1.5

2.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

559

1.22

0.84

1.1

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.74

0.82

1.4

1.3

—

146.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

189

0.63

0.81

1.3

1.4

pmol/l

26.9

227.9

—

(40765096) Chromosome analysis panel by Banding

1.61

0.81

1.0

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.70

0.80

1.0

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

374

1.26

0.79

5.9

3.3

1.8

1.4

0.30

303

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.79

0.0

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.79

0.0

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

303

1.29

0.79

1.4

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.82

0.79

5.7

8.2

—

(3021788) Differential panel - Synovial fluid

420

1.24

0.77

1.4

1.6

—

(3047189) Immunofixation for 24 hour Urine

1.59

0.77

1.2

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

323

1.27

0.75

1.4

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.84

0.73

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

763

1.17

0.73

1.5

1.8

—

(3030313) Adrenal Ab [Titer] in Serum

1.64

0.73

1.6

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.64

0.73

1.1

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

108

1.48

0.73

1.6

2.5

—

(4034850)

850

0.84

0.73

11.1

8.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

397

1.24

0.72

1.3

u/ml

1.1

3.0

1.40

198

(3006462) Nitrate [Presence] in Urine

125

1.44

0.72

4.8

2.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.61

0.72

4.7

6.8

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.61

0.72

4.4

6.5

—

(40758292) HTLV I+II Ab panel - Serum

1.67

0.72

1.2

1.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.67

0.72

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.67

0.72

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.67

0.72

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.67

0.72

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

318

1.26

0.70

1.0

1.1

iu/ml

14.3

9.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

342

0.76

0.69

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.85

0.68

1.0

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

178

1.35

0.68

1.4

1.5

u/l

4.7

6.5

1.37

151

(3033799) Differential panel - Peritoneal fluid

1.64

0.68

2.5

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

704

1.17

0.68

1.4

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

187

1.34

0.67

1.1

nmol/l

2.1

2.8

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

240

1.29

0.67

2.0

1.8

umol/l

21.1

22.9

0.16

231

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.49

0.66

1.4

1.5

ug/l

9.3

8.5

0.24

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.79

0.66

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

444

4183

1.07

0.66

2.1

2.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

268

1.27

0.65

1.6

1.7

56.3

0.00

177

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

125

1399

0.89

0.63

1.9

1.8

—

(4094501)

607

1.17

0.63

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

607

1.17

0.63

1.3

1.2

u/ml

9.3

3.5

—

(4133840)

1.52

0.62

1.4

1.2

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

1.60

0.61

1.0

1.1

u/ml

40.7

12.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

182

1.32

0.61

1.5

2.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

183

1.31

0.59

1.3

1.4

e6/l

3824.8

2085.5

0.39

127

(3051611) Lipemic interference index of Serum or Plasma

291

1.24

0.57

4.5

3.7

—

(3024869) Neuronal Ab [Presence] in Serum

1.67

0.56

1.2

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.62

0.55

1.7

1.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.62

0.55

5.8

10.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

194

1.29

0.55

1.0

1.1

miu/ml

1445.7

1396.4

0.10

194

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

150

1.33

0.55

1.5

2.9

umol/l

377.8

157.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

124

1.37

0.55

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

107

1.40

0.55

2.0

3.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

514

1.17

0.54

3.9

2.6

ug/min

110.5

121.2

0.07

324

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

330

1.21

0.54

2.0

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

645

1.15

0.54

2.0

2.4

nmol/l

1.0

0.8

1.87

545

(4211845)

142

1.34

0.54

4.6

2.7

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.54

0.53

1.0

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

322

1.21

0.53

2.1

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

609

1.15

0.53

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

600

1.15

0.52

2.0

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.52

0.52

1.7

3.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.52

0.52

1.7

3.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

223

1.26

0.52

2.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

305

1.21

0.51

1.1

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

179

1.29

0.51

1.4

1.6

u/ml

0.6

5.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

621

1.15

0.50

1.0

1.1

—

(3004451) EKG impression Narrative

1.41

0.50

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

1.46

0.50

2.5

1.7

—

(3008898) HLA-B27 [Presence]

131

1437

0.91

0.50

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

207

1.26

0.49

1.2

1.1

u/l

1.0

0.78

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

661

1.14

0.48

1.4

u/l

22.0

22.3

0.03

565

(3015076) Soybean IgE Ab [Units/volume] in Serum

344

1.19

0.48

1.0

1.1

u/ml

0.4

1.9

0.84

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

299

2817

1.07

0.48

7.6

5.6

—

(3000330) Specific gravity of Urine by Test strip

130

1184

1.10

0.48

3.8

2.9

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.52

0.48

1.3

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

326

1.20

0.48

2.1

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

643

1.14

0.48

2.1

2.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

229

2139

1.07

0.47

1.3

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.47

0.46

1.1

—

(3008295) Osmolality of Serum or Plasma

309

1.20

0.46

1.5

1.7

mosm/kgh2o

277.9

284.5

1.28

235

(40768806) Pleura Pathology biopsy report

155

1.29

0.46

1.3

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

173

1.27

0.46

2.2

2.3

u/field

1.9

2.0

0.04

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

200

1.25

0.46

1.3

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.38

0.45

1.1

1.2

—

(3017569) Oxygen content in Arterial blood

1.38

0.45

1.6

2.8

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

121

0.66

0.45

1.1

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

381

3626

1.06

0.45

1.9

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.40

0.45

1.1

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

165

1.27

0.44

1.3

1.4

e6/l

230620.8

95549.1

0.45

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

112

1.34

0.44

1.3

1.4

u/l

13.0

13.6

0.11

106

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

610

1.13

0.44

1.0

1.1

u/ml

2.7

3.5

0.22

285

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

121

1.32

0.44

1.2

1.4

—

765.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

781

1.12

0.43

1.3

1.2

u/ml

1.9

9.2

—

120

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

130

1.31

0.43

1.1

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

677

1.12

0.43

1.2

u/ml

63.9

42.9

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.61

0.43

4.0

3.3

mg/l

0.8

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

113

1.33

0.42

1.5

1.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.56

0.42

1.8

2.7

u/field

0.4

0.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

341

1.17

0.41

4.5

3.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

190

2029

0.93

0.41

1.5

1.4

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.2

—

0.2

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

20.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

351

1.17

0.41

1.2

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

105

1.33

0.41

3.6

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

105

1.33

0.41

3.6

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

268

1.19

0.40

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.33

0.40

1.0

1.1

ug/l

86.0

70.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

853

1.10

0.40

1.3

1.2

u/ml

48.6

39.6

—

(40768800) Prostate Pathology biopsy report

248

0.80

0.39

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

251

1.20

0.38

1.1

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

769

1.11

0.38

1.3

1.2

u/ml

2.5

7.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

280

0.82

0.38

1.1

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

124

1.29

0.38

5.0

5.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

124

1.29

0.38

2.5

2.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

130

1402

0.92

0.38

1.5

1.7

mg/l

6.0

4.2

0.54

953

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.35

0.37

1.2

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

107

1.31

0.37

3.6

1.8

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

125

1.28

0.36

1.4

2.4

—

27283.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

143

1.26

0.36

1.1

—

(3012441) Differential panel - Pleural fluid

153

1.24

0.35

1.3

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

244

0.82

0.35

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

152

1421

1.07

0.34

1.5

—

(1761868) Lipid panel - Serum or Plasma

1061

10818

0.97

0.33

2.5

2.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

265

1.17

0.33

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

265

1.17

0.33

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

173

1.21

0.32

1.2

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

322

1.15

0.32

2.1

1.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.28

0.32

6.5

8.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

155

1.23

0.32

1.1

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

266

1.17

0.32

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

113

1050

1.08

0.31

1.6

iu/ml

0.1

0.15

209

(3014599) Egg white IgE Ab [Units/volume] in Serum

389

1.13

0.31

1.2

1.3

u/ml

4.1

10.7

0.81

173

(4024509)

211

1.19

0.31

1.7

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

164

0.79

0.31

1.5

1.9

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.71

0.30

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

147

1.22

0.30

1.3

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.30

0.30

2.3

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

324

1.14

0.30

2.1

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

249

1.17

0.30

1.1

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

212

1.18

0.30

1.1

—

(4281824)

259

1.16

0.29

1.4

1.1

—

(3022670) pH of Venous cord blood

1.23

0.29

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

497

1.11

0.28

1.8

1.5

mmol/l

7.2

6.9

0.31

344

(1001926) Buprenorphine [Presence] in Urine by Screen method

191

1815

1.05

0.28

1.6

2.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

326

1.14

0.28

2.1

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

670

1.09

0.28

1.2

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

105

980

1.07

0.27

1.9

2.0

—

(3022689) Creatine [Moles/volume] in Urine

1.25

0.27

1.4

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

624

1.09

0.26

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.21

0.26

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

182

0.82

0.26

1.5

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

639

6237

1.03

0.26

2.4

2.2

—

(40768441) Liver Pathology biopsy report

234

1.15

0.26

1.3

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

299

0.87

0.26

2.4

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.28

0.26

1.4

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.30

0.26

1.4

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

703

6874

1.03

0.25

2.5

2.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

277

2666

1.04

0.25

2.5

2.7

ug/l

0.6

0.7

0.90

170

1618

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

263

1.14

0.25

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

263

1.14

0.25

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

263

1.14

0.25

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

105

1.24

0.24

1.5

1.4

—

4.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

217

1.15

0.24

1.4

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

116

1227

0.94

0.23

1.4

1.5

—

(3045716) Anion gap in Serum or Plasma

106

1.23

0.23

2.0

1.8

mmol/l

10.4

9.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.25

0.22

6.0

6.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.22

0.22

5.4

7.2

—

(44806420)

1.19

0.21

2.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.21

0.0

4.2

—

(3028707) Methadone [Presence] in Urine by Screen method

108

1021

1.06

0.21

1.9

2.8

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

576

5636

1.03

0.21

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

0.78

0.21

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.16

0.21

1.6

2.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

251

0.88

0.21

2.1

2.0

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3024316) Viscosity of Plasma

0.00

0.21

0.0

1.2

—

1.8

—

(3051651) Icteric interference index of Serum or Plasma

211

1.14

0.20

4.9

4.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.20

1.0

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

229

0.87

0.20

7.3

3.0

49.9

54.9

0.60

154

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

278

1.12

0.20

1.0

1.1

—

33.8

—

(3006653) Thiamine [Moles/volume] in Blood

155

1.16

0.19

1.1

1.4

nmol/l

139.2

131.1

0.35

155

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

269

1.12

0.19

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

109

1.19

0.18

1.1

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.21

0.18

2.7

1.2

—

(3001556) Androgen free Index in Serum or Plasma

1.17

0.17

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

219

2120

1.03

0.17

1.6

2.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.15

0.17

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.13

0.17

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

1.13

0.17

1.3

2.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.76

0.17

1.2

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.20

0.16

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.10

0.15

1.3

1.4

—

(3020650) Glucose [Presence] in Urine

1.15

0.15

1.1

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

327

0.92

0.15

1.5

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

121

1.16

0.15

1.1

—

(3027944) Amphetamines [Presence] in Urine

231

2251

1.03

0.13

1.6

2.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

122

1.15

0.13

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

278

2839

0.98

0.13

3.2

3.8

32.9

32.2

0.55

203

2028

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

527

5188

1.02

0.13

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

473

1.06

0.11

1.9

1.6

mmol/l

7.5

7.4

0.20

285

(3011288) Drugs identified in Urine by Screen method

164

1596

1.03

0.11

2.6

2.9

—

(3044927) Protein electrophoresis panel - Urine

182

1.10

0.11

1.1

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

233

2282

1.02

0.10

1.6

2.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

249

0.92

0.10

1.0

mmol/l

20.2

19.4

1.17

239

(4015189)

1.14

0.10

1.8

3.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.09

0.09

1.0

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.09

0.09

1.4

1.2

mmol/l

4.0

3.2

—

(44806071)

1.06

0.09

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

234

2299

1.02

0.08

1.6

2.1

—

(3020491) Glucose [Moles/volume] in Blood

226

0.93

0.08

2.1

1.6

mmol/l

7.1

6.2

0.51

174

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.81

0.08

1.2

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.78

0.08

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.78

0.08

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.09

0.08

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

411

1.05

0.07

1.3

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.81

0.07

1.0

1.1

u/ml

0.1

1.3

—

(3014271) Vancomycin [Susceptibility]

1.07

0.07

3.6

2.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

225

1.07

0.07

1.1

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

255

0.94

0.07

1.9

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

235

1.06

0.07

2.5

2.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

102

0.88

0.06

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

159

1566

1.02

0.05

1.3

miu/ml

196.6

229.0

0.60

768

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

100

1.10

0.05

1.2

—

(3027008) Opiates [Presence] in Urine

232

2293

1.01

0.05

1.6

2.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

210

2120

0.99

0.04

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

170

0.94

0.04

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

764

0.98

0.04

1.2

—

(3015183) Erythrocyte sedimentation rate

210

0.95

0.04

1.4

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

111

1.08

0.04

1.2

1.1

—

(3006598) pH of Arterial cord blood

239

0.96

0.03

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

211

1.04

0.02

1.4

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

218

0.96

0.02

1.2

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

570

1.02

0.02

1.2

1.1

iu/ml

259.5

963.3

—

157

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

107

0.93

0.02

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.07

0.02

1.1

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.07

0.02

1.1

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

143

1436

0.99

0.00

2.0

1.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

246

0.97

0.00

1.0

1.2

u/ml

76.1

18.2

0.35

179

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

414

1.01

0.00

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

133

0.98

0.00

1.1

—

(42870560) Thyrotropin [Units/volume] in Cord blood

292

0.99

0.00

1.0

mu/l

6.9

8.9

1.30

248

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

144

0.97

0.00

1.2

u/ml

5.4

5.6

0.02

120

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

170

1.00

0.00

1.1

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

154

0.97

0.00

2.3

3.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

154

0.97

0.00

1.5

1.3

mmol/l

6.8

6.4

0.15

140

(3003740) Influenza virus B Ag [Presence] in Specimen

740

1.00

0.00

1.3

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

743

1.00

0.00

1.3

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

195

1.02

0.00

1.5

1.2

—

69.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.96

0.00

1.0

1.5

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.98

0.00

1.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.01

0.00

1.1

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

1.00

0.00

1.4

1.2

14.2

3.1

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.0

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

0.0

3.3

—

1.9

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.97

0.00

1.1

1.3

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

177.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.1

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

29.5

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3002619) Bacteria identified in Specimen by Culture

0.99

0.00

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.91

0.00

1.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.00

0.00

2.8

5.4

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.01

0.00

3.4

5.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.91

0.00

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.91

0.00

4.5

2.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

111.4

—

(3035880) pH of Pleural fluid

1.01

0.00

1.5

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.00

0.00

1.5

1.3

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

20.8

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

4.6

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.3

—

93.9

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.95

0.00

1.0

u/ml

0.1

3.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_OTHER_CONGEN_MALFO and mortality.

Females

Parameter	HR [95% CI]	p-value
Q17_OTHER_CONGEN_MALFO	1.429 [1.25, 1.63]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.238

During the follow-up period (1.1.1998 — 31.12.2019), 949 out of 18511 females with Q17_OTHER_CONGEN_MALFO died.

Males

Parameter	HR [95% CI]	p-value
Q17_OTHER_CONGEN_MALFO	1.737 [1.53, 1.97]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.066

During the follow-up period (1.1.1998 — 31.12.2019), 1035 out of 12926 males with Q17_OTHER_CONGEN_MALFO died.

Mortality risk

Mortality risk for people of age

years, who have Q17_OTHER_CONGEN_MALFO.

N-year risk	Females	Males
1	0.13%	0.335%
5	0.835%	2.064%
10	2.058%	5.053%
15	4.03%	9.488%
20	7.249%	15.909%

Relationships between endpoints

↥

Index endpoint: Q17_OTHER_CONGEN_MALFO – Other congenital malformations

GWS hits: 5

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other congenital malformations

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints